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GENERAL INTRODUCTION
     Airway hyperresponsiveness (AHR) to a wide variety of pharmacological andlor
physical stimuli such as cholinergic agonists, histamine, leukotrienes, prostaglandins, cold air
and house dust is one of the most characteristic features of asthmatic airways (Chung &
Barnes; 1987). This phenomenon is reflected by bronchoconstriction in asthMatic patients who
inhale concentrations of these agents that have no effect in normal subjects. There is a close
relationship between the degree of bronchial responsiveness and the severity and frequency of
symptoms in asthma (Juniper et al., 1981), so AHR may play a fundamental role in the
pathophysiology of asthma. However, the precise mechanisms underlying the AHR remain to
be elucidated.
     It is well known that the autonomic nervous system regulates airway function, including
airway smooth muscle tone, seeretions, blood flow, mierovascular permeability and the
migration and release of infiammatory oe11s (Barnes, 1986a; 1990a). In addition to classical
cholinergic and adrenergic neural pathways, nonadrenergic noncholinergic (NANC) neural
mechanisms are also present in the airways. Although neuropeptides may mediate many of the
NANC effects in the airways (Barnes, 1992b; Bames et aL , 1991a; 1991b), it has recently
been recognized that nitric oxide (NO) may also function as an NANC neurotransmitter (Rand,
1992). There is abundant evidenoe that neural control of the airWays may be abnormal in
asthmatic patients, and that neurogenic mechanisms may contribute to the pathophysiology and
symptomatology of asthma including AHR (Nadel & Barnes, 1984). Because changes in
bronchomotor tone in asthmatic patients occur rapidly, it was suggested many years ago that
there might be an abnormality in autonomic neural control of the airways, with an imbalance
between excitatory and inhibitory pathways, resulting in excessively reactive airways. Several
types of autonomic dysfunction have been proposed in asthma, including enhanced
cholinergic, ct-adrenergic and nonadrenergic noncholinergic (NANC) bronchoconstrictor
mechanisms, or reduced P-adrenergic and NANC bronchodllator effects (Barnes, 1986a).
Various abnormalities in airway control have been described in asthma, although is ambiguous
whether that these are primary defects or secondary alterations of the disease or by its
treatment. Nevenheless, it is 1ikely that neural mechanisms contribute to the symptoms and
pathophysiology of asthma.
     Because cholinergic nerves are dominant neural bronchoconstrictor pathway in animal
and human airways (Barnes, 1986a), there has been considerable interest in whether
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cholinergic mechanisms are exaggerated in asthmatic patients. There are severai mechanisms
that might contribute to cholinergic bronchoconsniction in asthma (Widdicombe et al., 1991).
Nthough there is no direct evidence for an increase in central vagal drive to the airways in
asthmatic patients, indirect evidence is provided by an inerease in vagal cardiac tone (as
determined by the Valsalva manoeuvre and sinus arrhythmia gap) in asthmatic patients, and by
an increase in sinus arrhythmia gap at night, which correlates with nocturnal
bronchoconstriction (Barnes, 1986a), These observations indicate that the increased vagal tone
might be involved in asthma. It is also possible that the reflex bronchoconstriction due to
stimulation of sensory receptors in the akways (irritant receptors and C-fiber endings) might
be increased by infiammatory mediators. Several mediators, such as histamine, prostaglandins
and bradykinin, stimulate sensory receptors in the airways, and it is possible that these
receptors may be more easily triggered in asthmatic patients, since airway epithelium may be
damaged, or sensory endings may be sensitircd by inflammatory mediators such as
prostaglandins (Widdicombe et al., 1991). It is reported that bradykinin-induced
bronchoconstriction in asthmatic patients is partly reduced by pretreatment with an
anticholinergic agent (Barnes, 1992a). More recently, Fox et al. (1993) reported that, by using
single-fiber recordings in guinea pig airways, bradykinin is very effective in firing C-fibers,
whereas other inflammatory mediators have no such effect.
     One possible mechanism of the enhanced bronchoconstriction in asthmatic patients is
increased release of acetylcholine from parasympathetic nerve endings. 'Ihere is evidence for
facilitated neurotransmission in sensitized animals exposed to allergen (Undem et al. , 1991). It
has also been thought that infiammatory mediators facilhate acetylcholine release from
postganglionic nerve terminals via an effect on prejunctional receptors (Barnes, 1992a). For
example, thromboxane, prostaglandin D2 and tachykinins facilitate acetylcholine reiease from
postganglionic nerves in the airways and thereby exaggerate cholinergic reflex effects (Barnes,
1992a).
     At least three types of muscarinic receptors may be differentiated phamiacologically and
five distinct receptor subtypes have now been cloned. Muscarinic receptor subtypes have also
been recognized in the airways (Barnes, 1990b). Autoradiographic mapping shows that they
are differentially distributed in human airways (Mak & Barnes, 1990), and in situ
hybridization studies show a corresponding differential gene expression (Mak et al. , 1992). It
has been believed as the following: M, receptors in ganglia facilitate ganglionic
neurotransmission, Mz receptors act as feedback inhibitory reoeptors (autoreceptors) on
postganglionic nerve terminals and inhibit acetylcholine release, and M, receptors on airway
smooth muscle induce bronchoconstriction directly (Barnes, 1990a).
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     Although adrenergic nerves do not control smooth muscle in human airways directly
 (Barnes, 1992a), P-agonists have a dramatic effect on relieving asthmatic
bronchoconstriction. So, it is logical to suggest that there might be a defect in 6-adrenoceptor
function in asthmatic patients. From the same reason, it seems probably that circulating
catecholamines may play a more important role in regulation of bronchomotor tone (Barnes,
1986c). Although the catecholamines, noradrenaline, adrenaline and dopamine, are present in
the circulation, only adrenaline seereted by the adrenal medulla has physiological effects. Some
studies have demonstrated that airways from patients who have died of asthma fail to relax
normally to jsoprenaline, suggesting a defect in P-adrenoceptor function in airway smooth
muscle (Goldie et al., 1986; Bai, 1991). On the other hand, ct-adrenoceptors which mediate
bronchoconstriction have been demonstrated in airways of several species, and may only be
demonstrated under certain experimental conditions. 'Ihere is now, however, considerable
doubt about the role of q-adrenoceptors in the regulation of tone in human aiiways as it has
proved difficult to demonstrate their presenoe functionaliy or by autoradiography (Spina et al. ,
1989), and ct-blocking drugs do not appear to be effective as bronchodilators.
     Recently, it has widely been accepted that the excitatory and inhibitory NANC nervous
systems are present in the airways as the third autonomic nervous system. The NANC
bronchoconstrictor effect is mediated by sensory neuropeptides, predominantly neurokinin A,
as described below. On the other hand, in human airways, bronchodllator nerves that are non-
adrenergic in nature have also been demonstrated both in vitro using electrical field stimulation
and in vivo using reflex activation with chcmical or mechanical initation (Lammers et al. ,
1992). A defect in the NANC bronchodilator nerves has been proposed in asthma, as this is
the only neural bronchodilator pathway in human airways. It has been reported that a defect in
NANC bronchodilatation is observed after antigen exposure in cats (rvliura et al., 1992).
However, in patients with mild asthma, no reduction in the NANC bronchodilator reflex is
apparent (Lammers et al. , 1989). Vasoactive intestinal polypeptide and nitric oxide are thought
as the neurotransmitters of bronchodilator NANC nerves in the airways (Barnes, 1991a; Rand,
1992).
     One of the most important characteristics in asthmatic patients is severe airway
inflammation. There has been inereasing interest in the role played by the inflammatory
changes present in the airways of asthmatic patients in the development and maintenance of
AHR. The airvvays of patients died by acute asthma attack show several characteristics of a
severe infiammatory response. The violent submucosal swelling, that contributes in part to the
airway obstruction in asthma is due to congested blood vessels, plasma exudation and
inflammatory cells infiltration consisting predominantly of eosinophils (Dunnill, 1960;
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Houston et al., 1953). In addition, there is marked epithelial cell loss as shown by the
denudation of the airway surface and by clumps of epithelial cells in sputum, and there is also
an increased mucus secretion (Dunnil1, 1960; Houston et al. , 1953). No detailed physiological
examination of the airways of stable asthmatic patients is available but bronchoalveolar lavage
of these patients reveals a 1arger number of eosinophils and, to a lesser extent, neutrophils
within the airway lumen when compared to normal subjects (Godard et al. , 1982; Flint et al. ,
1985). Biopsies of the airway mucosa of stable asthmatics have confirmed the presence of
cpithelial cell damage, particularly of the ciliated cell type (Laitinen et al., 1985) and the
submucosal infiltration of eosinophils (Glynn & Michaels, 1960). Thus, regardless of the
extent of asthmatic symptoms, it seems likely that airway inflammation is a common feature of
bronchial asthma,
     The immediate type of bronchoconstriction observed in allergic bronchial asthmatics has
been thought to oocur as a result of the antigen-antibody reaction on airway luminal surface
and/or submucosa. So, it has been proposed that the mast oell is the initiator of inflammatory
responses to allergic stimuli in the airways (Casale & Kaliner, 1984). Although mast cells are
abundant in lung tissue (Guerzon et al. , 1979), they only form a relatively sman proponion of
the cells recovered from the airway lumina of normal and asthmatic subjects (Flint et al. ,
1985). It has been suggested that activation and degranulation of these relatively few mast cells
lead to inereased mucosal permeability with subsequent activation of tissue mast cells (Hogg,
1981). The mast cells can release a wide variety of inflammatory mediators that can mimic
some of the features of bronchial asthma including smooth muscle contraction and mucous
secretion (Casale & Kaliner, 1984). It also generates chemotactic factors for inflammatory cells
(e.g., eosinophils, neutrophils), such as hydroxyeicosatetraenoic acids (HETIE's) and
leukotriene B, (Robinson & Holgate, 1985; Wasserman, 1983). On the other hand, it has been
reported that 15-HETE, generated from eosinophils (Turk et al. , 1982) and airway epithelial
cells (Hunter et al. , 1985), and major basic protein released from eosinophils can activate
mediator release from mast cells (Goetzl et al. , 1983; O' Donell et al. , 1981). It seems that the
oe11-oe11 interactions are highly complex.
     Alveolar maerophages are in greater abundance within the lumen of the airways than
mast cells, and also generate chemotactic factors for infiammatory cells (Gosset et al. , 1984;
Hunninghake et aL , 1978). This phenomenon is thought to occur through the activation of
their low-affinity surface IgE receptors by antigen (Joseph et al. , 1983). It was also reported
that alveolar macrophages can release the putative inflammatory mediator, platelet-activating
factor (PAF) (Arnoux et al., 1980; 1983). •
     It is generally accepted that eosinophils have a pro-inflammatory role. 'Ihe infiltrating
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eosinophil can generate mediators that could be involved in enhancing bronchial
responsiveness. It is reported that eosinophilic cationic protein and major basic protein, both
major components of eosinophilic granules (Ackerman et al., 1983), are cytotoxic to the
respiratory epithelium (Gleich et al. , 1979) and could therefore account for the denudation of
the epithelium observed in asthmatic patients (Filley et al., 1982). Eosinophils were also
reported to have the capacity to generate leukotriene C, (Welier et al. , 1983) and PAF (Lee et
al., 1984).
     The neutrophil is an extremely potent cell capable of generating prostaglandins,
thromboxane, leukotrienes and PAF, despite its relative paucity in the airway wall of asthmatic
patients (Chung & Barnes, 1987). However, few studies reported the implication of
neutrophils in allergic asthmatic patients.
     Recently, PAF has been considered as one of the most important mediators which induce
AHR (Chung & Barnes, 1987). PAF causes a long-lasting, intense inflammatory reaction in
the airways with the participation of neutrophils, macrophages, epithelial cells and platelets
(Camussi et al. , 1983) and increased microvascular permeability and oedema (Humphrey et
al., 1982; Heffner et al., 1983). In addition to its capacity to reproduce these pathological
features that are characteristic of the asthmatic airways, PAF is a potent bronchoconstrictor
agent in human in vivo and induces AHR (Cuss et al. , 1986). Evidence for PAF release has
been obtained following antigenic challenge in asthmatic patients by the demonstration of a
selective reduction of the aggregatory response of circulating platelets to PAF (Thompson et
al. , 1984). It has also been reported that increased levels of circulating PAF were detected in
asthmaticpatients (Grandel et al. , 1983). The exact mechanisms by which PAF causes AHR
remain to be determined. It has been suggested that PAF may mediate the epithelial damage
seen in the asthmatic airways through the recruitment and stimulation of eosinophils. This
epithelial damage may result in the exposure of C-fiber endings which may then be stimulated
by various mediators released during the inflammatory process (Coleridge & Coleridge,
1984). For instance, bradykinin acts on Ofiber endings to cause the release of sensory
neuropeptides such as substance P (SP) and neurokinin A (NKA) (Bames, 1986b). This local
reflex may serve to enhance inflammatory responses seen in the asthmatic airways with
mucous hypersecretion and bronchial oedema through these neuropeptides. In additjon, it has
also been reported that these neuropeptides potentiate mediator release and inflammatory cell
infiltration (Payan et al. , 1984). On the other hand, it was also reported that PAF antagonists
had no effect on the anaphylactic bronchoconstriction although these antagonjsts inhibited the
PAF-induced bronchoconstriction in guinea pigs (Danko et al. , 1988). These findings suggest
that PAF would not be a final andlor important mediator involved in the asthmatic reaction
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and/or the pathogenesis of the AHR, although PAF has a potency to cause bronchoconstriction
(Danko et al., 1988; Misawa & Takata, 1988) and AHR (Chung et ai., 1986b).
     More reoently, the connibution of the neurogenic infiammation in the airways in
asthmatic patients has been noticed. Unmyelinated sensory nerves (C-fibers) in the airways
contain several neuropeptides, such as SP, NKA and calcitonin gene-related peptide (CGRP),
which may be released from sensory nerves on antidromical activation of the nerve via an axon
reflex mechanism. Release of neuropeptide from sensory nerves in the airways might result in
inflammation of the airways. 'Ihis is readily demonstrated in some species but whether it is
relevant in human airways is not yet certain. In a• chronic animal model of antigen-induced
AHR, depletion of sensory neuropeptides by prior systemic treatment wmb capsaicin, the
pungent agent of hot peppers, results in the abolition of the hyperresponsiveness (Matsuse et
al. , 1991), whereas, in acute models of allergen exposure, capsaicin pretreatment has no effect
(L6-tval1 et al. , 1991). This suggests that sensory neuropeptides may become more important
in chronic inflammation.
     It has been reported that SP-immunoreactive nerves are increased in the airways of
patients who died of asthma (Ollerenshaw et aL , 1991). This could be the result of chronic
inflammation resulting in proliferation of sensory nerves in the airways. Inflammatory sigfials
may stimulate increased synthesis of neuropeptides in sensory neurons.
     The denudation of airway epithelium in asthmatic airways may expose sensory nerve
endings, and these may be triggered or sensitized by certain infiammatory mediators, such as
prostaglandins. Asthma may therefore be associated wnh hyperaesthesia of the airways. For
instance, it is 1ikely that cough and chest tightness, common symptoms of asthma, are a
reflection of this airway hyperaesthesia. Bradykinin is thought to be particularly impertant in
activating sensitized sensory nerves and, when inhaled to asthmatic patients, it induoes marked
dyspnoea and coughing, which are reminjscent of an asthma attack (Barnes, 1992a).
Bradykinin is formed from plasma which exudes into the asthmatic airway lumen as a result of
microvascular leakage. Activation of these sensory nerves may then cause antidromic
stimulation of branches of the nerves, with release of their neuropeptides via an axon reflex
(Barnes, 1992a).
     SP and NKA belong to the tachykinin family and activate different subtypes of
tachykinin reoeptor. NKA is a potent constrictor of human bronchi in vitro (Solway & Leff,
1991) and is considerably more potent than SP, indicating that an NK,-receptor is present on
airway smooth muscle. SP is a potent inducer of microvascular leakage in the airways and is
more potent than NKA in this respect. SP also stimulates mucous secretion more potently both
in animal and human bronchi in vitro. It is also reported that SP is by far the most potent of
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these peptides in stimulating goblet oell seeretion (Kuo et aL , 1990). 'Ihis may be important in
asthma, as goblet cells are the only source of mucous glycoproteins in peripheral airways. All
of these inflammatory responses are thought to be mediated by NK,-receptors. It is reported
that Northern analysis of asthmatic lungs indicates an inereased amount of NK,-receptor
mRNA, which may result from the effects of various cytokines on NK,-receptor gene
transcription (Peters et al. , 1992).
     These sensory neuropeptides are degraded predominantly by neutral
metalloendopeptidase (NEP, EC 3.4.24.11, enkephaiinase) which is localized mainly in
airway epithelium. An inhaled NEP inhibitor, thiorphan, potentiates the bronchoconstrictor
effect of inhaled NKA in normal human subjects, indicating the presence of NEP on the
surfaoe of human airways (Cheung et al., 1992), and NEP has been localized
immunocytochemically and its gene expression determined using in situ hybridization in
human airways (Baraniuk et al. , 1991). However, Nichol et al. (1992) reported that another
NEP inhibitor, acetorphan, does not cause bronchoconstriction in astimatic patients, indicating
that there may not be inereased basal release of neuropeptides in asthmatic airways. Whether
NEP activity is reduced in astlmatic airways is not yet certain, and this is an interesting issue
including the role of sensory neuropeptides on the pathogenesis of AHR.
     To understand the underlying mechanisms of AHR in allergic asthmatic patients, it is
very important to develop an animal model of AHR which closeiy resembles that observed in
asthmaticpatients. 'Iherefore, in my present experiment, at first, I tried to develop an animal
model of AHR by using sensitized rats. Some of the mechanisms of the pathophysiology of
AHR cleared by using this animal model of AHR wil1 be introduoed and discussed in this
thesis.
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AIM&SCOPE
'Ihe specific aims of the proposed research are:
In Chapter 1;
          To understand the underlying mechanisms of AHR in allergic asthma, I tried to
     develop an animal model of AHR by using actively sensitized rats. The correlation
     between AHR and airway inflammation was examined by using this antigen-induced
     AHR model. Whether AHR is also obtained at the in vitro bronchial level was then
     examined.
In Chapter 2;
          Strain differences in the pathogenesis of antigen-induced AHR were examined by
     using Brown-Norway (a high IgE responder), Long-Evans Cinnamon (which has
     dysfunction of helper T cell) and Wistar rats (as a normal responder).
In Chapter 3;
          The effects of ozagrel (a thromboxane A, synthase inhibitor) and CV-3988 (a PAF
     receptor antagonist) on the pathogenesis of antigen-induced AHR in rats were examined.
In Chapter 4;
          'Ihe effects of sensory neuropeptides depletion on the pathogenesis of antigen-
     induced AHR in rats were examined. The effect of repeated antigenic challenge to
     sensitized rats on the airway tissue NEP activity was also examined.
In Chapter 5;
          'Ihe effect of NEP inhibitors on the airway responsiveness to acetylcholine in
     nonsensitized normal rats was examined. The mechanism of the increased airway
     responsiveness to acetylcholine by neuropeptides was also investigated.
In Chapter 6;
          The origin of Ca2' contributing to the enhancement of acetylcholine-induced
     bronchial srnooth muscle constriction in airway hyperresponsiveness induced by antigen
     challenge was investigated. '
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                      CHAPTER 1:
Establishment of an animal model of airway
                 hyperresponsiveness
Introduction
     Nonspecific airway hyperresponsiveness (AHR) is a common feature in individuals with
allergic bronchial asthma (Cockcroft et al., 1977; Magnussen & Nowak, 1989). In allergic
asthma, inhalation of allergen causes not only an immediate and reversible bronchoconstriction
but also AHR to stimuli such as histamine and acetylcholine (ACh). The importance of the
increased responsiveness in the pathogenesis of asthma has been suggested by its correlation
with the severity of this disease (Cockcroft et al. , 1977; Hargreave et al., 1981). It is thus very
important to understand the underlying mechanisms of AHR for the sake of astlma therapy.
     To understand the mechanisms of AHR, various animal models have been developed.
O' Byme et al. reported that prostaglandin F,. (O' Byrne et al. , 1984), leukotriene B, (O' Byrne
et at. , 1985) and ozone (Aizawa et al. , 1985) induced AHR to ACh in normal dogs. However,
it is unlikely that these dog models resemble human allergic asthma because'these animals were
not made allergic. A frcquently used animal model is the model using guinea pigs that are
sensitized with ovalbumin (OA) together with some adjuvant (Ishida et tzL , 1989; Boichot et
al. , 1991). However, this species has been considered to be immunologically different from
humans with regard to the mechanisms of allergic asthma involving antibody (Wanner et al. ,
1990).
     Because allergic bronchoconstriction in rats has ceitain features in common with human
allergic asthma, rats show good potential as an allergic asthmatic animal model (Elwood et al. ,
1991; Renzi et al. , 1992). It has been demonstrated that the immunoglobulin E (IgE) antibody
was easily generated when rats were sensitized with DNP-Ascan's antigen (Tada & Okumura,
1971). The sensitized rats also exhibit early and late asthmatic responses to antigen inhalation
(Eidelman et al. , 1988). In the present study, to investigate the underlying mechanisms of
AHR, we first tried to develop a new animal model of AHR by utilizing this species. The
relationship between AHR and airway inflammation in our rat model was also examined.
-
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Experiment 1-1: Effect of single antigenic challenge on in vivo airway
responsiveness in actively sensitized rats.
Materials and methods
Antigen challenge
     Specific-pathogen-free male Wistar rats weighing 230-314 g (6-8 weeks of age),
purchased from Charles River Japan, Inc., were housed under standard laboratory conditions
with free access to food and water. Animals were sensitized with 2,4-dinirophenylated Ascan's
suum extract (DNP-Asc, 2 mg protein, s. c. ) together with killed Bordetella pertussis (2xlO'O)
as an adjuvant and were boosted by DNP-Asc (O.5 mg protein, i. m. ) 5 days later, according to
the method of Tada and Okumura (1971). Eight days after the first immunization, the rats were
challenged by inhaling DNP-Asc (6 mg protein/ml, 5-6 ml) with an ultrasonic nebulizer (TUR-
3000, Nihon Kohden, Tokyo) for 20 min under conscious state in a plexiglass box (300x200
mm, height: 150 mm). These animals were designated as the single challenge group and used
for experiments 24 hr after the antigenic challenge. Control rats reoeived the same
immunization, but inhaled saline instead of the DNP-Asc challenge dose.
ln vivo determination ofairway responsiveness
     The determination of airway responsiveness to ACh or neurokinin A (NKA) was
measured 24hr after the antigenic challenge. Rats were anesthetized with urethane (2 glkg,
i.p.), placed in the supine position and ventilated artificially through a tracheal cannula at a
frequency of 70 breaths/min. Respiratory volume was adjusted at the beginning of the
experiment so that ventllation overfiow (VO) was O.5 ml in each rat. Spontaneous respiration
was stopped by an injection of pancuronium bromide (1 mglkg, i.v.). The bronchomotor tone
was measured by the modified Konzett-Rdssler method (Konzett & R6ssler, 1940) (Fig. 1-1).
lhe lung was inflated at a fixed volume of air under a constant pressure (5 cmH20), and VO
was continuously recorded with a combination of a pneumotachograph (TP-602T, Nihon
Kohden) and an integrator (EI-601G, Nihon Kohden). Systemic blood pressure was
monitored with a pressure transduoer (DX-3eO, Nihon Kohden) from a cannula inserted into
the left carotid artery, and heart rate was measured with a tachometer (AT-601G, Nihon
Kohden) with the systemic blood pressure as the trigger. All the above parameters were
recorded on a polygraph (RM-6000, Nihon Kohden).
     The rats were subjected to cumulative inhalation of ACh (O.OOI-O.03 9o) or NKA
-
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(O.OOOI-O.Ol 9o), each for 3 min, by aerosolizing the solution contained in a specially devised
plastic cylindrical chamber (capacity: 25 ml) that was introduced in an ultrasonic nebulizer
(TUR-3200, Nihon Kohden). The ultrasonic nebulizer with the plastic chamber was placed
into the respiratory circuit so that the aerosolized mist was inhaled into the airway each time of
ventilation.
Dntgs
     The following drugs were used: acetylcholine chloride (purchased from Dalichi
Pharmaceutical Co., Ltd., Tokyo); NKA (from Peptide Institute, Inc., Osaka); pancuronium
bromide (from Sankyo Pharmaceutical Co., Ltd., Tokyo) and urethane (ethyl carbamate; from
Sigma Chemical Co., Ltd., St. Louis, USA). Heparin sodium was from Kodama Co., Ltd.
(Tokyo).
     For the in vtvo studies, ACh, NKA and pancuronium bromide were freshly made just
before use. Urethane was dissolved in saline and stocked at room temperature. Heparin
solution was diluted freshly in saline each day.
Stattstical analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student' s t-test for unpaired data or Cochran-Cox test. 'Ilhe potency ratio of the
in vivo bronchoconstrictor response to ACh or NKA was calculated by parallel line assay.
-
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Results
    Inhalation of four cumulative aerosols of ACh (O.OOI, O.O03, O.Ol and O.03 9o, each for
3 min) to anesthetized control rats induced a concentration-related bronchoconstriction (Fig. 1-
2). When the animals were challenged only once with DNP-Asc, the conoentration-response
curve to ACh was shifted to the left 3.2-fold in terms of the concentration ratio, 24 hr after the
challenge, The airway responsiveness to ACh was significantly enhanoed at concentrations of
O.OOI and O.O03 cre (pÅqO.05). Similar results were obtained with NKA (O.OOOI, O.OO03,
O.OOI, O.O03 and O.Ol %, each for 3 min) (Fig. 1-3); the concentration-response curve was
shifted to the left (sixfold) 24 hr after the single antigenic challenge. The airway
responsiveness to NKA was significantly enhanoed at conoentrations of O.OO03 and O.OOI 9o
(pÅqO.05).
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The concentration-response curves of bronchomotor response to
aerosolized acetylcholine (ACh) after single challenge with DNP-Asccm's
antigen (Asc) in anesthetized rats. Each point represents the mean with
S.E. from 5 (saline control: Sal) and 6 (Asc) experirnents. V.O.:
ventilation overflow as an index of bronchoconstriction (see Materials
and methods). "pÅqO.05 vs. control group.
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The concentration-response curves of bronchomotor response to
aerosolized neurokinin A (NKA) after single challenge with DNP-Asccuts
antigen (Asc) in anesthetized rats. Each point represents the mean with
S.E. from 5 (saline control: Sal) and 6 (Asc) experiments. V.O.:
ventilation overflow as an index of bronchoconstriction (see Materials
and methods). *pÅqO.05 vs. control group.
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Experiment 1-2: Effect of repeated antigenic challenge on in vivo airway
responsiveness in actively sensitized rats.
Materials and methods
Antigen challenge
     Specific-pathogen-free male Wistar rats weighing 230-314 g (6-8 weeks of age),
purchased from Charles River Japan, Inc., were used. Animals were sensitized and boosted
with DNP-Asc as described in Experiment 1-1. Eight days after the first immunization, the
rats were challenged by inhaling DNP-Asc (6 mg protein1mi, 5-6 mi) with an ultrasonic
nebulizer (TUR-3000, Nihon Kohden, Tokyo) for 20 min under conscious state in a
plexiglass box (300x200 mm, height: 150 mm). Then the animals received 3 times repeatedly
antigenic challenge every 48hr by the same challenge method as described above. These
animals were used for experiments 24 hr after the 1ast antigenic challenge. Control rats
received the same immunization, but inhaled saiine instead of the DNP-Asc challenge dose.
In vivo determination ofairway responsiveness
     The determination of airway responsiveness to ACh or neurokinin A (NKA) was
measured 24hr after the last antigenic challenge by the method described in Experiment 1-1 .
Dnigs
     The following drugs were used: acetylcholine chloride (purchased from Daiichi
Pharmaceutical Co., Ltd., Tokyo); NKA (from Peptide Institute, Inc., Osaka); pancuronium
bromide (from Sankyo Pharmaoeutical Co., Ltd., Tokyo) and urethane (ethyl carbamate; from
Sigma Chemical Co., Ltd., St. Louis, USA). Heparin sodium was from Kodama Co., Ltd.
(Tokyo).
     For the in vtvo studies, ACh, NKA and pancuronium bromide were freshly made just
before use. Urethane was dissolved in saline and stocked at room temperature. Heparin
solution was diluted freshly in saline each day.
Stattstical analyses
    All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student' s t-test for unpaired data or Cochran-Cox test. 'fiie potency ratio of the
in vivo bronchoconstrictor response to ACh or NKA was calculated by paiallel line assay.
-
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Results
    The airway responsiveness to inhaled ACh was much more markedly inereased 24 hr
after the repeated antigenic challenge.
     Figure 1-4 shows the conoentration-response curve for inhaling ACh 24 hr after the last
antigenic challenge. In the repeated challenge group, a dramatic leftward shift of the
concentration-response curve (12.0 times; its 95 9o confidence interval: 6.1-63.9, pÅqO.05) was
observed, as compared with the single challenge group. Similar results were obtained with
cumulative inhalation of NKA; the concentration-response ourve was shifted to the left (12.4-
fold; its 95 9o confidence interval: 9.0-19.5, pÅqO.05) 24 hr after the last antigenic challenge
(Fig. 1-5).
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                        Figure 1-4
The concentration-response curves of bronchomotor response to
aerosolized acetylcholine (ACh) after repeated challenge with DNP-
Ascarts antigen (Asc) in anesthetized rats. Each point represents the mean
with S.E. from 6 (saline control: 3Sal) and 7 (3Asc) experiments. V.O.:
ventilation overflow as an index of bronchoconstriction (see Materials
and methods). "pÅqO.Ol and *"pÅqO.OOI vs. control group.
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The concentration-rcsponse curves of bronchomotor response to
aerosolized neurokinin A (NKA) after repeated challenge with DNP-
Ascan's antigen (Asc) in anesthetized rats. Each point represents the mean
with S.E, from 5 (saline control: 3Sal) and 8 (3Asc) experirnents. V.O.:
ventilation overfiow as an index of bronchoconstriction (see Materials
and methods). 'pÅqO.05, *"pÅqO.Ol and '**pÅqO.OOI vs. control group.
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Experiment 1-3: Comparison of antigen induced-bronchoconstriction
between single and repeated antigen challenged rats.
Materials and methods
Animals
     Specific-pathogen-free male Wistar rats weighing 230-314 g
purchased from Charles River Japan, Inc., were used. Animals were
with DNP-Asc as described in Experiment 1-1 .
(6-8 weeks of age),
sensitircd and boosted
In vivo determination ofDNP-Asc-induced bronchoconstrictt'on
     N 8 days after the first immunization in the single chalenge group and at the third
challenge in the repeated challenge group, the antigenic challenge was performed under
anesthesia by inhaling DNP-Asc for 20 min through the tracheal cannula, and the DNP-Asc-
induced immediate type of bronchoconstriction was measured by the modified Konzett-R6ssler
method (Konzett & R6ssler, 1940) described in Experiment 1-1 and compared between the
two groups.
Dritgs
     'Ihe following drugs were used: pancuronium bromide (purchased from Sankyo
Pharmaceutical Co., Ltd., Tokyo), urethane (ethyl carbamate; from Sigma Chemical Co.,
Ltd., St. Louis, USA) and heparin sodium (from Kodama Co., Ltd., Tokyo).
     Pancuronium bromide were freshly madejust before use. Urethane was dissolved in
saline and stocked at room temperature. Heparin solution was diluted freshly in saline each
day.
Stat]tstical analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student's t-test for unpaired data or Cochran-Cox test.
Results
    Eight days after the first immunization, inhalation of aeTosolized DNP-Asc (6 mg
protein/ml, 20 min) to sensitized rats under anesthesia (First challenge) induced an increase in
ventilation overflow (VO as an index of bronchoconstriction) (Table 1). A similar, but slightly
stronger, response was confimed at the last antigenic challenge in the repeated challenge
-
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group (Last challenge). However,
the maximal inerease in' VO (VO...
DNP-Asc.
there was no significant difference between the groups in
) nor the time for reaching VO,.. (T,.,.) during inhaiation of
Table 1-1. The maximai increase in ventilation overflow (AVO.,,.)
and the time for reaching VOma. (T,..) during DNP-Asc (6 mg
protein!ml) challenge for 20 min under anesthesia
n AVO... (ml) T.. (min)
First challenge
Last challenge
6
5
O.41Å}O.05
0.51Å}O.05ns
15.1Å}1.8
13.8Å}1.6ns
AVOrm, and T.,. were expressed as the meanÅ}S.E. First challenge: 8
days after the first immunization (matched for the antigenic challenge
of the single challenge group). Last challenge: 12 days after the first
immunization (matched for the last antigenic challenge of the repeated
challenge group). "S: no significant differenoe from the first challenge
group.
-
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Experiment 1-4: Time course of in vivo airway hyperresponsiveness to
acetylcholine after repeated antigenic challenge.
Materials and methods
Antigen challenge
     Specificpathogen-free male Wistar rats weighing 230-314 g (6-8 weeks of age),
purchased from Charles River Japan, Inc., were used. Animals were sensitized, boosted and
repeatedly challenged with DNP-Asc as described in Experiment 1-2. Control rats received
the same immunization, but inhaled saline instead of the DNP-Asc challenge dose.
In vivo determination ofairway responsiveness
     The determination of airway responsiveness to ACh was measured 12, 24, 48 or 72 hr
afier the last antigenic challenge by the method described in Experiment 1- 1 .
Passive cutaneous anaphylaxis (PCA)
     To measure PCA titer, the blood specimens were obtained from the heart at 8 and 12
days after the first immunization and at 12, 24, 48 and 72 hr after the last antigenic challenge.
The blood specimens were immediately ice-cooled for 10 min and then centrifuged (3000 rpm,
4 eC for 10 min). The sera obtained were stored at -35 OC unti1 used.
     Serial dilutions (4-512) of the serum obtained from individual bleedings were injected
intradermally in O.05 ml quantities into the shaved backs of normal rats. After 48 hr, the rats
were i.v. -injected with DNP-Asc (2 mg protein1200 g body weight) into the tail veins. After 30
min, they were exsanguinated from the cervical aortae, and the skin was reflected for
measurement of the extent of extravasation of the dye. When the diameter was 25 mni, the
dilution was determined to be end point.
Drugs
     'Ihe foilowing drugs were used: acetylcholine chloride (purchased from Daiichi
Pharmaceutical Co., Ltd., Tokyo); pancuronium bromide (from Sankyo Phamiaceutical Co.,
Ltd., Tokyo); Evans blue (from Merck Co., Ltd., New Jersey, USA) and urethane (ethyl
carbamate; from Sigma Chemical Co., Ltd., St. Louis, USA). Heparin sodium was from
Kodama Co., Ltd. (Tokyo).
     ACh and pancuronium bromide were freshly made just before use. Evans blue and
urethane were dissolved in saline and stocked at room temperature. Heparin solution was
- 20-
diluted freshly in saline each day.
Stattstical analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student' s t-test for unpaired data or Cochran-Cox test. 'Ihe PCA titer of each
group is expressed as the mean and its statistical significance was determined by the Wilcoxon
rank-sum test.
Results
     Figure 1-6 shows the time course of airway responsiveness to ACh after the last DNP-
Asc challenge in the repeated challenge group. The airway responsiveness to ACh was
stronger in the following order, 24 hrÅr12 hrÅr48 hrÅr72 hr after the last DNP-Asc challenge in
the repeated challenge group. The most severe airway hyperresponsiveness was thus shown at
24 hr after the last antigenic challenge. At 72 hr after the last antigenic challenge, however, the
airway responsiveness almost recovered to the control level.
     The antibody titer was measured by 48-hr passive cutaneous anaphylaxis (PCA) at 8 and
12 days after the first immunization and at 12, 24, 48 and 72 hr after the last antigenic
challenge (Table 1-2). Ihere was no significant difference in PCA titers among the groups,
except that the titer at 72 hr after the last antigenic challenge was significantly lower than that at
24 hr (pÅqO.05).
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                        Figure 1-6
lhe time course changes in response to acetylcholine (ACh) after the 1ast
DNP-Asccmis antigen (Asc) challenge in anesthetized rats. Each point
represents the mean with S.E. from 4 to 8 experiments. V.O.: ventilation
overflow as an index of bronchoconstriction. "pÅqO.05, "pÅqO.Ol and
"" pÅqO.OOI vs. control group.
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Table 1-2. 'Ihe passive cutaneous anaphylaxis (PCA) titers at
vanous tme polnts
n mean PCA titer PCA range
Day 8
Day 12
Challenge after
     12 hr
24 hr
48 hr
72 hr
5
5
5
14
5
7
21.2
30.4
22.8
40.0
32.4
12e3"
2-64
8-64
2-64
8-256
2-128
2-32
PCA titer was expressed as the mean of the end points determined as
deseribed in Materials and methods. Day 8: the day just before
the first antigenic challenge. Day 12: the day just before the 1ast
antigenic challenge. Challenge after 12, 24, 48 and 72 hr: 12, 24, 48
and 72 hr after the 1ast antigenic challenge. 'pÅqO.05 vs. challenge
after the 24-hr group (Wilcoxon rank-sum test).
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Experiment 1-5: Effect of repeated antigenic challenge on in vitro
airway responsiveness in actively sensitized rats.
Materials and methods
Antigen challenge
     Specific-pathogen-free male Wistar rats weighing 230-314 g (6-8 weeks of age),
purchased from Charles River Japan, Inc., were used. Animals were sensitized, boosted and
repeatedly challenged with DNP-Asc as described in Experiment 1-2. Control rats received
the same immunization, but inhaled saline instead of the DNP-Asc challenge dose.
In vitro determination ofairway responsiveness
     Twenty-four hours after the last antigenic challenge, the rats were saerificed by a blow to
the head and exsanguinated. The trachea and bronchus were rapidly removed, cleaned of
adhering connective tissues and cut open longitudinally along its ventral surface. About a 5-
mm length of the tracheal strip was isolated 5 mm under the 1arynx (5-6 cartilages), and the left
main bronchial strip was also isolated (about 5-mm length, 8-9 cartilages). Each tissue strip
was then suspended in a 10-ml organ bath, at a resting tension of 1.0 g. The isometrical
contraction of each strip was measured with a force-displacement transducer (TB-612T, Nihon
Kohden) and recorded on a polygraph (RM-85, Nihon Kohden). lhe organ bath contained
modified Krebs-Henseleit solution with the following composition: 118 mM NaCl, 4.7 mM
KCI, 2.5 mM CaCL, 1.2 mM MgSO,, 25.0 mM NaHCO,, 1.2 mM KH,PO, and 10.0 mM
glucose. The buffer solution was maintained at 37 eC and oxygenated with 95 9o O,-5 9o C02.
During an equilibration period in the organ bath, the tissues were washed three to four times at
15 to 20 min intervals and equilibrated slowly to a baseline tension of 1.0 g for both strips. A
further period of 15 min was required for tissue stabilization. The concentration-response
curves for ACh and serotonin (5-HT) were constructed cumulatively, with a concentration
range of 10-7-10` M. A higher concentration of agonist was sucoessively added after
attainment of a plateau response to the previous concentration. Under these conditions,
reproducible concentration-response curves were obtained on the same tissue strips.
     In our in vitro experiments, NKA (108-10'6 M) had no effect on most of the tracheal and
main bronchial strips, so that we used 5-HT instead of NKA as a pharmacological stimulant in
the in vitro experiments.
Drugs
-
24-
     The following drugs were used: acetylcholine chloride (purchased from Daiichi
Pharmaceutical Co., Ltd., Tokyo) and serotonin (5-hydroxytriptamine hydrochloride).
     Just before use in the in vitro studies, fresh soiutions of ACh and serotonin were made
in Krebs-Henseleit solution (composition described above).
Stadsti`cal analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student's t-test for unpaired data or Cochran-Cox test.
Results
     ACh elicited a concentration-dependent contractile response of the rat tracheal and
bronchial strips (Figs. 1-7 and 1-8). In the control (saline inhalation) group, the contractile
response elicited by 104 M ACh was 1.11Å}O.06 g (n=8) in the trachea (Fig. 1-7) and O.38Å}O.
05 g (n=8) in the bronchus (Fig. 1-8). As compared with the control group, the contractile
response of the bronchial strips was significantly enhanced 24 hr after the last antigenic
challenge in the repeated challenge group; the contractile response elicitod by 104 M ACh was
1.00Å}O.08 g (n=6, pÅqO.OOI). No change in responsiveness of the tracheal strip (n=6) was,
however, observed even after the antigenic challenge.
     5-HT elicited relatively small contractile responses of the rat tracheal and bronchial strips
(Figs. 1-9 and 1-10). In the control group, the maximal contractile response elicited by 104 M
5-HTwas O.07Å}O.03 g (n=5) in the tracheal strips (Fig. 1-9) and that elicited by 3xlO'5 M5-
HT in the bronchial strips was O.05Å}O.Ol g (n=5) (Fig. 1-10). 'Ihe contractile responses
caused by 5-HT were also significantly enhanced in the bronchial strips which were excised 24
hr after the last antigenic challenge; the maximal contractile response elicited by 3xlO-5 M 5-HT
was O.19Å}O.04 g (n=5, pÅqO.05).
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                    Figure 1-7
'Ilie concentration-response curves of contractile responses of the isolated
trachea to acetylcholine (ACh) after 3 times repeated challenge with DNP-
Ascan's antigen (Asc) or saline (Sal) inhalation in sensitized rats. Each
point represents the mean with S.E. from 8 (control: 3Sal) and 6 (3Asc)
expenments.
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                 Figure 1-8
The concentration-response curves of contractile responses of the isolated
bronchus to acetylcholine (ACh) after 3 times repeated challenge with
DNP-Asccvis antigen (Asc) or saiine (Sal) inhalation in sensitized rats.
Each point represents the mean with S.E. from 8 (control: 3Sal) and 6
(3Asc) experiments. '"pÅqO.Ol and "'pÅqO.OOI vs. control group.
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'Ihe concentration-response curves of contractile responses of the isolated
trachea to serotonin (5-H"I) after 3 times repeated challenge with DNP-
Ascaris antigen (Asc) or saline (Sal) inhalation in sensitized rats. Each
pointrepresents the mean with S.E. from 5 (control: 3Sal) and 5 (3Asc)
expenments.
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                        Figure 1-10
The concentration-response curves of contractile responses of the isolated
bronchus to serotonin (5-HT) after 3 times repeated challenge with DNP-Asc(zris
antigen (Asc) or saline (Sal) inhalation in sensitized rats. Each point represents the
mean with S.E. from 5 (control: 3Sal) and 5 (3Asc) experiments. 'pÅqO.05 vs.
control group.
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Experiment 1-6: Effect of repeated antigenic challenge on airway
microvascular leakage.
Materials and methods
Antigen challenge
     Specific-pathogen-free male Wistar rats weighing 230-314 g (6-8 weeks of age),
purchased from Charles River Japan, Inc., were used. Animais were sensitized, boosted and
singly andlor repeatedly challenged with DNP-Asc as described in Experiment 1-1 and 1-2.
Control rats received the same immunization, but inhaled saline instead of the DNP-Asc
challenge dose.
Determination of airway microvtzscular lecrkage
     At twenty-four hour or other time points after the last antigenic challenge, the rats were
anesthetized with urethane (2 glkg, i.p.). Airway vascular permeability was quantified by the
extravasation of Evans blue dye (E.B.) using the modification of the method of Evans et al.
(1987), which correlates well with extravasation of radiolabeled albumin (Udaka et al. , 1970).
E.B. (30 mg/ml in saline, filtered with paper filter), 30 mglkg, and heparin (600 U/kg) were
administered by i, v. -injection. Twenty minutes later, the animals were exsanguinated from the
abdominal aorta, and then the thorax was opened and a blunt-ended 13-gauge needle was
passed through the right ventricle into the pulmonary artery. The pulmonary veins were incised
to allow the outflow of perfusate, and the airways and lungs were perfused with 20-30 ml of 1
9o paraformaldehyde in citrate-buffered saline (pH 3.5) to remove intravascular dye and to fix
the tissues. After then, the trachea main bronchus and lungs were removed and their wet
weights were measured.
    E.B. was extracted by incubating tissues in 1 ml (trachea and main bronchus) or 3 ml
(lungs) of 100 9o formamide at 60 Åé for 24 hr, and ks concentration was determined by light
absorbance at 620 nm (U-2000 spectrophotometer, Hitachi) and interpolation on a standard
curve of E.B. concentrations (3.125-50 paglml). E.B, content from each sample was expressed
as nanograms per milligram wet weight of tissue.
Drztgs
     Evans blue was obtained from Merck Co., Ltd. (New Jersey, USA) and was dissolved
in saline and stocked at room temperature. Heparin sodium was from Kodama Co., Ltd.
(Tokyo) and was diluted freshly in saline each day.
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Stattstical analyses '
    All the data are expressed as the mean with S.E. Statistical significance of difiierence was
deteimined by Student's t-test for unpaired data or Cochran-Cox test.
Results
    Figure 1-11 .shows E.B. extravasation in the tracheal, main bronchial and lung tissues at
24 hr after the single challenge and at 12 or 24 hr after the iast challenge of the 3 times repeated
challenge. E.B. extravasation in the trachea was significantly increased at 24 hr after the
repeated challenge (pÅqO.05 vs. control). In the main bronchus, E.B. extravasation was
significantly increased at 24 hr after the single challenge (pÅqO.Ol vs. control), but a more
marked increase in E.B. extravasation was observed at 12 and 24 hr after the repeated
challenge (pÅqO.OOI and pÅqO.Ol vs. single challenge group, respectively). (in the other hand,
E.B. extravasation in the lungs was increased in none of the challenge groups.
    The E.B. extravasations in the tracheal (12.16Å}4.15 nglmg tissue, n=5), main bronchial
(11.65Å}2.00 ng!mg tissue, n=5) and lung (3.62Å}O.24 nglmg tissue, n=5) tissues 48 hr after
the last antigenic challenge were not significantly different from the respective control value
(data not shown).
-
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                      Figure 1-11
The changes in amount of extravasated Evans blue dye (ng Evans blue
dye lmg wet weight tissue) in the rat trachea (left panel), main bronchus
(middle panel) and lungs (right panel). Each column represents the mean
with S.E. from 8 (control: 24 hr after inhaling saline), 11 (24 hr after the
single antigenic challenge), 5 (12 hr after the 1ast antigenic challenge) and
8 (24 hr after the 1ast antigenic challenge) experiments. 'pÅqO.05,
** pÅqO.Ol and "'* pÅqO.OOI vs. control group. ##pÅqO.Ol and
###pÅqO.OOI vs. single challenge group.
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Experiment 1-7: Histological changes in airway tissues after repeated
antigenic challenge.
Materials and methods
Antigen challenge
     Specific-pathogen-free male Wistar rats weighing 230-314 g (6-8 weeks of age),
purchased from Charles River Japan, lnc., were used. Animals were sensitized, boosted and
singly andlor repeatedly challenged with DNP-Asc as deseribed in Experiment 1-1 and 1-2.
Control rats receivod the same immunization, but inhaled saline instead of the DNP-Asc
challenge dose.
Histological examination
     For histological examination, 5 to 7 rats of each group (control, single challenge and
repeated challenge groups) were used. 'Ilhese animals were exsanguinated from the abdominal
aorta, and the lower airway was removed after opening thorax. 'Ihen the tissue was gently
washed with norrnal saline and fixed in neutral formalin solution. The trachea, main bronchus
and lung were cut into 3-5 mm chips, and each of the chips was embedded in paraffin by a
standard technique. The paraffin sections were stained with hematoxylin and eosin.
Results
     Figures 1-12 and 1-13 show the main bronchiai tissues stained with hematoxylin and
eosin from the control and repeatedly challenged rats, respectively. Twenty-four hours after
the repeated challenge, mast cell and inflammatory cell (monocytes, lymphocytes, polynuclear
cells, etc.) infiltration was markedly increased. The infiltration of these cells was more severe
in the repeated challenge group (Fig. 1-13) than in the single challenge group (data not
shown). In the repeated challenge group, the main bronchus was affected more severely than
the trachea and lungs. Furthermore, epithelial cells were moderately changed (e.g. , increased
and hypertrophied goblet cells), especially in the main bronchus.
-
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A photograph showing the main bronchus from the controi rat (
antigenic challenge) (Å~400). Hematoxyljn-eosin staining.
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A photograph showing the main bronchus from the
challenged rat (Å~400). Hematoxylin-eosin staining.
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Discussion
     Our results demonstrated that repeated antigenic challenge caused a distinct AHR
(enhanoed airway responsiveness to inhaled ACh and NKA) and airway inflammation
(increased airway mierovascular leakage and histological change) in actively sensitized rats.
The peak of AHR to ACh was shown at 24 hr after the 1ast antigenic challenge. At this time
point, it was found that the AHR could be obtained even in the in vitro level, that is, in
bronchiai tissue. A severe airway infiammation was demonstrated at 12-24 hr after the last
antigenic challenge in the bronchus.
     ACh and NKA were used to determine the in vivo airway responsiveness. ACh was
frequently used for the test of AHR in clinical diagnosis. NKA, one of the putative
neurotransmitters of the excitatory non-adrenergic, non-cholinergic nervous system, is a potent
bronchoconstrictor agent (Solway & Leff, 1991). In the present study, the AHR to ACh was
completely blocked by atropine (data not shown), indicating that there existed a muscarinic
hyperreactivity. However, this is not a specific hyperreactive response because the airway
responsiveness to NKA was also enhanced.
     When rats were sensitized with DNP-Asc antigen aocording to the method of Tada and
Okumura (1971), the 48 hr PCA titer (IgE antibodies are involved) is known to reach the
maximal level at 8 days after the first immunization. 'Ihus, at first, this time point was selected
to carry out the antigenic challenge (to elicite the immediate asthmatic response) under
unanesthesia. The objective symptoms observed were analogous to those of ailergic bronchial
asthma (e.g. , abnorrnality of breaths) in al1 the animals used.
     Presently, the airway responsiveness to ACh and NKA were significantly enhanoed at
24 hr after the single challenge, but the enhanced level was not so potent. Generally, with
regard to allergic bronchial asthmatios, they are continually exposed to a certain antigen (e.g. ,
house dust). Reoently, with this view in mind, repeated antigenic challenge to sensitized
animals has been attempted by some investigators (Bellofiore & Martin, 1988; Gundel et al. ,
1990; Kleeberger et al. , 1985). On the other hand, Bellofiore and Martin (1988) reported that
the gradual desensitization to OA antigen was elicited after 6 times repeated challenge in
Brown-Norway rats. In our experiments, the antigenic challenge protoco1 of 3 times repeated
challenge every 48 hr successfully produoed a marked increased responsiveness to ACh and
NKA 24 hr after the last challenge of the repeated challenge.
     Twenty-four hours after the last antigenic challenge, the in vitro airway responsiveness
to ACh and 5-HT were aiso enhanced in the main bronchus but not in the trachea. The airway
microvascular leakage was more markedly inereased in the bronchus than in the trachea.
Furthermore, in our histological study, infiltration of inflammatory cells was much more
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severe in the bronchus than in the trachea. It has been thought that airway inflammation is
induced by some chemical mediators such as prostaglandins, leukotrienes (LTs), thromboxane
A, (TXA,), and platelet-activating factor (PAF) derived from the inflammatory oe11s (e.g. ,
mast cells, neutrophils, eosinophils), which results in AHR (O'Byrne, 1986; Chung, 1986).
Additionaly, neuropeptides which are contained in the sensory nerve endings (Barnes, 1986),
may be also involved in the occurrence of airway infiammation. The differenoe in the present
results between the tracheal and main bronchial regions is not now explainable. It was,
however, possible that because the distribution of these inflammatory cells might be more
abundant in the main bronchus, the chemotaxis of these infiammatory oe11s might be caused
more strongly in the main bronchus than in the trachea. Another possibility is that the neural
controi of the main bronchus might be essentially different from that of the trachea (e. g. , the
regional difference of responsiveness to ACh, carbachol (Vomanen & Tirri, 1981) and LTC,
(Szarek & Evans, 1988) was reported in rats and excitatory nonadrenergic, noncholinergic
innervation is much abundant in the bronchial region than in the tracheal region in guinea pigs
(Stretton et aL , 1992)). Furthermore, it is possible that there may be a difference in physical
adhesion of the antigen to the airway lumenal surface as compared to its adhesjon in the
bronchus. 'Ihis regional difference inthe airway inflammation was 1ikely to Teflect the regional
difference in the AHR in the in vitro experiments also.
     It has been reported that an antigenic challenge to sensitized guinea pigs (Ishida et al. ,
1990) and rabbits (Tanaka et al., 1991) resulted in an airway smooth muscle
hyperresponsiveness in vitro. These animals also obtained AHR in the in vivo level (Ishida et
al., 1989; Tanaka et al., 1991). 'Ihese findings therefore suggest that the increased airway
smooth muscle responsiveness itself may be refiected in the in vivo AHR. Our results that the
responsiveness to ACh and 5-HT were enhanced in the bronchial tissue in vitro supports this
speculation. However, attempts to demonstrate hyperresponsiveness of isolated airway
smooth muscle strips from asthmatios in vitro have so far produced varied results. There
seems to be little or no increase in the sensitivity of airway strips from asthmatics (obtained
post-mortem) (Goldie et al. , 1986; Cerrina et al. , 1986). In contrast, some studies, particulaly
those using surgical specimens, have described a substantial inerease in muscle responsiveness
(Schellenberg & Foster, 1984; de Jongste et aL, 1987; Bai, 1990).
     In our findings, a close relationship between the bronchial inflammation and the AHR
was demonstrated. That is, thepeak of the airway inflammation was shown at 12-24 hr after
the last antigenic chakenge and the peak of the AHR wag shown at 24 hr after the 1ast
challenge. When dogs inhaled ozone, a close association was observed between the
development of AHR and an acute inflammatory Tesponse in the airways, as measured by an
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influx of neutrophils into the epithelial and sub-epithelial layers of the airways (Holtzman et
al., 1983) and bronchoalveolar fiuid (Fabbri et al., 1984). Furthermore, in other animal
preparations such as rabbits (Marsh et al. , 1985), guinea pigs (Murlas & Roum, 1985) and
even in humans (Seltzer et al. , 1986), airway inflammation had also occurred at the same time
as the development of AHR. Gibson et al. (1991) reported that stable asthmatic individuals
who were subjected to the provocation test with allergen inhalation demonstrated an increased
histamine airway responsiveness at 24 hr after the provocation, accompanied by airway
inflarnmation. 'Their results are in good accordance with ours in terms of time course. In the
present study, the airway inflammation (as evaluated by the E.B. exudation and histological
examination) was induced in the main bronchus after the single antigenic challenge to
sensitized rats, and a more severe inflammatory reaction was induced after the repeated
antigenic challenge. It is 1ikely that the antigenic challenge to sensitized rats caused an aiiway
infiammation which was followed by AHR.
     The present rat AHR model is considered to be usefu1 for studying the underlying
mechanisms of pathogenesis of AHR and for screening therapeutic drugs for AHR.
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                         CHAPTER 2:
Strain differences in airway hyperresponsiveness
                repeated antigenic challenge
after
Introduction
    As described in CHAPTER 1, we developed an animal model of AHR by using male
Wistar rats that were actively sensitized with DNP-Ascan's antigen (DNP-Asc) and challenged
3 times by inhaling the aerosolized antigen. It is documented that there is a strain difference in
imniediate asthmatic response caused by DNP•-Ascan's antigen in rats (Misawa et aL , 1987).
To study the mechanisms involved in nonspecific airway hyperresponsiveness (AHR), the
selection of a suitable strain is important. There has however been no report in which AHR
response was compared arnong strains of the rat. In the present study, we therefore
investigated the strain differences in liability for AHR among the three strains of rats: Brown-
Norway (BN), a high IgE responder strain (Pauwels et al., 1978; Pauwels et al., 1979),
Long-Evans Cinnamon (LEC), anew mutant which develops spontaneous hepatitis (Yoshida
et al., 1987) and has dysfunction of helper T oells (Agui et al., 1990; Yamada et al., 1991) and
Wistar.
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Experiment 2-1: Strain differenoes in in vivo airway responsiveness to
acetylcholine after repeated antigenic challenge.
Materials and methods
Animals
     Male Wistar rats (6 weeks of age, 170-190 g) were purchased from Charles River Japan,
Inc. and male Brown-Noiway rats (BN; 6 weeks of age, 120-150 g) and male Long-Evans
Cinnarnon rats (LEC; 6 weeks of age, 110-140 g) were kindly gifted from this company. All
these rats were specific-pathogen-free and housed under standard laboratory conditions with
free access to food and water.
Sensitization and antigenic challenge
     The method for inducing AHR was described in Experiment 1-2. Animals were
sensitized with 2,4-dinitrophenylated Ascanis suum extract (DNP-Asc, 2 mg protein, s.c.)
together with Bordetellapertussis (2xlOiO) as an adjuvant and were boosted by DNP-Asc (O.5
mg protein, i.m.) 5 days later, aocording to the method of Tada and Okumura (1971). Eight
days after the first immunization, the rats were challenged by inhaling DNP-Asc (6 mg
proteinlml, 5-6 ml) with an ultrasonic nebulizer (TUR-3000, Nihon Kohden, Tokyo) for 20
min under conscious state in a plexiglass box (300x200 mm, height: 150 mm). Then the
animals received 3 times repeated antigenic challenge every 48 hr with the same challenge
method described above. Control rats reoeived the same immunization, but were inhaled saline
instead of the DNP-Asc challenge.
In vivo determination ofairway responsiveness
     The determination of airway responsiveness to ACh was done 24 hr after the last
antigenic challenge. Rats were anesthetized with urethane (2 g/kg, i.p.), placed in the supine
position and ventilated artificially through a tracheal cannula at a frequency of 70 breaths/min.
Respiratory volume was adjusted at the beginning of the experiment so that ventilation
overflow (VO) was O.5 ml in each rat. Spontaneous respiration was stopped by pancuronium
bromide (1 mglkg, i.v.). The bronchomotor tone was measured by the modified Konzett-ROs
sler method (Konzett and ROssler, 1940) as described in' Experiment 1-1. The lung was
inflated at a fixed volume of air under a constant pressure (5 cmH,O), and VO was
continuously recorded with a combination of pneumotachograph (TP-602T, Nihon Kohden)
and integrator (EI-601G, Nihon Kohden). Systemic blood pressure was monitored with a
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pressure transducer (DX-300, Nihon Kohden) from a cannula inserted into the left carotid
artery. All the above parameters were recorded using a polygraph (RM-6000, Nihon Kohden).
     ACh (O.OOI-O.03 9o) was cumulatively inhaled each for 3 min to the rats by aerosolizing
the solution contained in a specially devised plastic cylindrical chamber (capacity: 25 ml) which
was introduced in an ultrasonic nebulizer (TUR-3200, Nihon Kohden). The ultrasonic
nebulizer with the plastic chamber was placed into the respiratory circuit for the aerosolized
mist being inhaled into the airway at each time of ventilation.
Drugs
     The following drugs were used: 2,4-dinitrobenzene sulfonic acid sodium salt (Tokyo
Kasei Co., Tokyo); aoetylcholine chloride (Daiichi Pharmaceutica1 Co., Tokyo); pancuronium
bromide (Sankyo Co., Tokyo) and urethane (Sigma, St. Louis, USA).
     ACh and pancuronium bromide were dissolved and/or diluted in saline at the usage.
Statistical analyses
     All the data are expressed as the mean with S.E. Statistica1 significance of difference was
determined by Student's t-test for unpaired data, Cochran-Cox test or two way analysis of
variance (ANOVA).
Results
     At each antigenic challenge, the symptoms (e.g. abnormality ofbreaths) were observed
in the animals. The symptoms observed were remarkable in degree in Wistar and Brown-
Norway (BN) rats, but were moderate in Long-Evans Cinnamon (LEC) rats.
     In all the three strains of rats, inhalation of four cumulative aerosols of ACh (O.OOI,
O.O03, O.Ol and O.03 qo; each for 3 min) to anesthetized normal (non-sensitized) rats induced a
concentration-related increase in ventilation overflow (V.O.), that is, a bronchoconstriction
(Figs. 2-1, 2-2 and 2-3). The normal rats of BN strain were most sensitive to ACh among
respective normal rats of the three strains (F[,,,,]=6.291, pÅqO.05 vs. Wistar).
     In Wistar rats, the sensitization itself was without effect on the airway responsiveness to
ACh. However, the concentration-response curve to inhaled ACh was markedly shifted to the
left 24 hr after the last antigenic challenge (F[,,,,]=18.492, pÅqO.Ol). The airway
responsiveness to ACh was significantly enhanced at concentrations ofO.OOI 9o (pÅqO.05 vs.
normal and sensitized control) and O.03 9o (pÅqO.05 vs. normal and pÅqO.Ol vs. sensitized
control) (Fig. 2-1). In BN rats, the concentration-response curve to ACh of the sensitized
control group was slightly shifted to the left, although not significant, as compared with the
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normal group. Twenty-four hr after the last antigenic challenge, no enhancement was observed
when compared with the sensitized control group. The aiiway responsiveness to ACh was,
however, significantly shifted to the left (F[,,,,]=13.042, pÅqO.Ol), and enhanoed at a
concentration of O.03 qo (pÅqO.05) as compared with the normal group (Fig. 2-2). On the other
hand, no significant change in responsiveness to ACh was observed in LEC rats after the
sensitization or repeated antigenic challenge (Fig. 2-3).
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                        Figure 2-1
lhe conoentration-response curves of bronchomotor response to
aerosolized acetylcholine (ACh) after 3 times repeated challenge with
DNP-Ascaris antigen (Asc) in sensitized Wistar rats. The airway
responsiveness to cumulatively inhaled ACh was determined 24 hr after
the last antigenic challenge. A; nonsensitized control group (Normal). O;
animals that were sensitized and inhaled saiine (Sal) 3 times instead of
Asc (control). e; animals that were sensitized and challenged 3 times
 (3Asc 24 hr). Each point represents the mean with S.E. from 4-8
experiments. "pÅqO.05 vs. Normai group, and #pÅqO.05 and ##pÅqO.Ol vs.
control group.
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                     Figure 2-2
'Ihe concentration-response curves of bronchomotor response to
aerosolized acetylcholine (ACh) after 3 times repeated challenge with
DNP-Ascaris antigen (Asc) in sensitized Brown-Norway rats. The airway
responsiveness to cumulatively inhaled ACh was determined 24 hr after
the last antigenic challenge. A; nonsensiti2x:d control group (Normal). O;
animals that were sensitized and inhaled saline (Sal) 3 times instead of
Asc (control). e; animals that were sensitized and challenged 3 times
(3Asc 24 hr). Each point represents the mean with S.E. from 4-8
experiments. *pÅqO.05 vs. Normal group.
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                        Figure 2-3
The concentration-response curves of bronchomotor response to
aerosolized aoetylcholine (ACh) after 3 times repeated challenge with
DNP-Ascaris antigen (Asc) in sensitized Long-Evans Cinnamon (IEC)
rats. The airway responsiveness to cumulatively inhaled ACh was
determined 24 hr after the last antigenic challenge. A; nonsensitized
control group (Normal). O; animals that were sensitized and inhaled
saline (Sal) 3 times instead of Asc (control). e; animals that were
sensitized and challenged 3 times (3Asc 24 hr). Each point represents the
mean with S.E. from 4-8 experiments. "pÅqO.05 vs. Normal group.
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Experiment 2-2: Strain differences in in vitro airway responsiveness to
acetylcholine and electrical field stimulation after
repeated antigenic challenge.
Materials and methods
Sensitization and antigenic challenge
     Male Wistar, Brown-Norway (BN) and Long-Evans Cinnamon (LEC) rats were
sensitized and received repeated antigenic challenge by the method deseribed in Experiment
2-1.
In vitro determination of airway responsiveness
     Immediately after the in vivo study as deseribed in Experiment 2-1, animals were
thoracotomized and bled from the heart to collect the antisera under anesthesia, and the trachea
and bronchus were rapidly removed and cleaned of adhering connective tissues. About 5 mm
length of the left main bronchus was isolated (8-9 cartilages) and the resultant tissue ring
preparation was then suspended in a 10 ml organ bath at a resting tensipn of O.5 g. The
isometrical contraction was measured with a foroe-displaoement transducer ('ITB-612T, Nihon
Kohden) and recorded on a polygraph (RM-85, Nihon Kohden). 'Ihe organ bath contained
modified Krebs-Henseleit solution with the following composition (mM); NaCl 118.0, KCI
4.7, CaCh 2.5, MgSO, 1.2, NaHCO, 25.0, KH,PO, 1.2 and glucose 10.0. 'Ihe buffer
solution was maintained at 37 eC and oxygenated with 95 9oO,-5 9oCO,. During an
equilibration period in the organ bath, the tissues were washed three to four times at 15 to 20
min intervals and equilibrated slowly to a base line tension of O.5 g. Fifteen min after the last
washing, the concentration-response curve to ACh (10'7-10'3 M) was constructed
cumulatively. A higher concentration of ACh was successively added after attainment of a
plateau response to the previous conoentration. After determination of ACh responsiveness,
the tissues were frequently washed out at 15 to 20 min intervals. Then the airway
responsiveness to electrical field stimulation (EFS; 20 V, O.5 msec, O.5-64 Hz for 15 sec) was
also deterrnined by using an electronic stimulator (SEN-3301, Nihon Kohden) after the
equilibration period. A higher frequency of EFS was performed at 4 min intervals. Under
these conditions, reproducible conoentration- and frequency-response curves were obtained on
the same tissue strip. In these in vitro studies, the data were expressed as increased tension per
dry tissue weight (glmg dry weight).
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Drugs
     The following drugs were used: 2,4-dinitrobenzene sulfonic acid sodium salt (Tokyo
Kasei Co., Tokyo) and acetylcholine chloride (Daiichi Pharmaceutical Co., Tokyo).
     ACh was dissolved and diluted in modified Krebs-Henseleit solution.
Stattstical analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student's t-test for unpaired data, Cochran-Cox test or two way analysis of
variance (ANOVA).
Results
     ACh elicited a conoentration-dependent contractile response of the bronchial rings of all
the three strains of rats (Figs. 2-4, 2-5 and 2-6). In Wistar rats, the sensitization was without
effect on the airway responsiveness to ACh. However, the response to cumulatively
administered ACh (10'7-10-3 M) was significantly augmented 24 hr after the last antigenic
challenge as compared with normal group (F[,,,,]=6.794, pÅqO.05) and sensitized control group
(F[i,s,]=11•242, pÅqO.Ol) (Fig. 2-4). The contractile responses elicited by 10'3 M ACh were the
following: normal group; 1.49Å}O.29 glmg dry weight (n=5), sensitized control group; 1.26Å}O.
31 g/mg dry weight (n=5), and repeatedly challenged group; 2.16Å}O.37 g/mg dry weight
(n=6). On the other hand, neither the sensitization nor the repeated antigenic challenge had
significant effect on the airway responsiveness to ACh in BN and IEC rats (Figs. 2-5 and 2-
6).
     Figures 2-7, 2-8 and 2-9 illustrates the frequency-response curves for EFS response of
the isolated left main bronchi of normal, sensitized and repeated challenged rats. EFS elicited a
frequency-dependent contractile response of the bronchial tissues of the strains; the contractile
responses elicited by EFS were completely abolished by tetrodotoxin (10" M) or atropine (10`
M) (data not shown), indicating that these responses were mediated by neural, especially
cholinergic component. In al1 the strains of rats, the sensitization was without significant effect
on the EFS-induced contractile responses. However, the frequency-response curves were
significantly shifted to the left after repeated antigenic challenge in Wistar (F[,,,,]=20.936,
pÅqO.Ol) and BN rats (F[,,,,]=32.351, pÅqO.Ol), but not in LEC rats.
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                    Figure 2-4
'Ihe concentration-response curves for contractile responses to
aoetylcholine (ACh) of the main bronchus isolated from 3 times repeated
challenged Wistar rats with DNP-Ascan's antigen (3Asc 24 hr; e) or
from 3 times saline inhaled Wistar rats that had been sensitized (3Sal 24
hr; O). (ipen triangle (A); non-sensitized control group (Normal). Each
point represents the mean wnh S.E, from 4-8 experiments. Twenty-four
hours after the 1ast challenge, the conoentration-response curve was
significantly augmented (pÅqO.05 vs. Normal and pÅqO.Ol vs. control by
ANOVA).
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The concentration-response curves for contractile responses to
acetylcholine (ACh) of the main bronchus isolated from 3 times repeated
challenged Brown-Norway (BN) rats with DNP-Ascaris antigen (3Asc 24
hr; O) or from 3 times saline inhaled BN rats that had been sensitized
(3Sal 24 hr; O). (ipen trimzgle (A); non-sensitized control group
(Normal). Each point represents the mean with S.E. from 4-8
experiments. No significant difference among the groups was observed in
BN rats.
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                    Figure 2-6
The concentration-response curves for contractile responses to
aoetylcholine (ACh) of the main bronchus isolated from 3 times repeated
challenged Long-Evans Cinnamon (LEC) rats with DNP-Ascaris antigen
(3Asc 24 hr; e) or from 3 times saline inhaled LEC rats that had been
sensitized (3Sal 24 hr; O). Cipen tn'angle (A); non-sensitized control
group (Normal). Each point represents the mean with S.E. from 4-8
experiments. No significant difference among the groups was observed in
LEC rats.
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The frequency-response curves for contractile responses to electrical field
stimulation (20 V, O.5 msec, O.5-64 Hz for 15 sec) of the main bronchus isolated
from 3 times repeated challenged Wistar rats with DNP-Asccvis antigen (3Asc 24
hr; e) or from 3 times saline inhaled Wistar rats that had been sensitized (3Sal 24
hr; O). Qpen triangle (A); non-sensitized control group (Normal). Each point
represents the mean with S.E. from 4-8 experiments. Twenty-four hours after the
last challenge, the frequency-response curves were significantly shifted to the left
(pÅqO.Ol vs. Normal or control by ANOVA).
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The frequency-response curves for contractile responses to electrical field
stimulation (20 V, O.5 msec, O.5-64 Hz for 15 sec) of the main bronchus
isolated from 3 times repeated challenged Brown-Noiway (BN) rats with
DNP-Ascmiis antigen (3Asc 24 hr; e) or from 3 times saline inhaled BN
rats that had been sensitized (3Sal 24 hr; O). Qpen triangle (A); non-
sensitized control group (Normal). Each point represents the mean with
S.E. from 4-8 experiments, Twenty-four hours after the last chailenge,
the frequency-response curves were significantly shifted to the left
(pÅqO.Ol vs. Norrnal or control by ANOVA).
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The frequency-response curves for contractile responses to electrical field
stimulation (20 V, O.5 msec, O.5-64 Hz for 15 sec) of the main bronchus
isolated from 3 times repeated challenged Long-Evans Cinnamon (LEC)
rats with DNP-Ascan's antigen (3Asc 24 hr; e) or from 3 times saline
inhaled MC rats that had been sensitized (3Sal 24 hr; O). Ctpen triangle
(A); non-sensitized control group (Normal). Each point represents the
mean with S.E. from 4-8 experiments. No significant differenoe arnong
the groups was observed in LEC rats.
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Experiment 2-3: Effect of repeated antigenic challenge on bronchial
tissue wet to dry (wetldry) weight ratio.
Materials and methods
Sensitization and antigenic challenge
     Male Wistar, Brown-Norway (BN) and Long-Evans Cinnamon (LEC) rats were
sensitized and received repeated antigenic challenge by the method deseribed in Experiment
2-1.
Determination of bronchial tissue wet to dry (wetldry) weight ratio
     To determine the extent of the airway edema, the wetidry weight ratio of each bronchial
tissue was determined. After the in vitro study, the wet weight of the bronchial tissue was
measured and then the tissue was placed in a freeze-dry system for 24 hr. Then the tissue dry
weight was measured and the wetldry weight ratio was calculated.
Stattstical analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
detefmined by Student's t-test for unpaired data or Cochran-Cox test.
Results
     In Wistar rats, the dry tissue weights (mg) were the following: normal group; 1.02Å}O.06
(n=5), sensitized control group; O.98Å}O.10 (n=5), and repeated challenged group; O.92Å}O.08
(n=6); there was no significant difference among the groups. However, the wetidry weight
ratio of the left bronchial tissue from repeated challenged group (4.48Å}O.34) was significantly
increased as compared with that from sensitized control group (2.77Å}O.10, pÅqO.Ol) (Fig. 2-
10). On the other hand, the wetidry weight ratio of the left bronchial tissues from repeated
challenge group of BN (4.05Å}O.35, n=7) or LEC rats (3.72Å}O.14, n=7) had no significant
changes as compared with respective sensitized control groups (3.69Å}O.16 (n=7)' and 3.04Å}O.
37 (n=5)).
- 53-
o
•...
NN{. 4.0
ca
'6
si
NÅrb'2.0
xe
s
o
              Wistar Brown-Norway LEC
                       Figure 2-10
The strain differences in the wet to dry (wetidry) weight ratio of the
bronchial tissue isolated from 3 times repeatedly challenged rats with
DNP-Ascaris antigen (3Asc 24 hr) or from 3 times saline inhaled rats that
had been sensitized (3Sal 24 hr; control). Wistar (left), Brown-Norway
 (middle) and Long-Evans Cinnamon (IJiC; right) rats were used.
Twenty-four hours after the last challenge, the tissue wet weight of the
main bronchial ring was determined and then the tissue was freeze-dried
for 24 hr. Then the wetidry weight ratio was calculated. '"pÅqO.Ol vs.
respective control group.
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Experiment 2-4: Strain differences in the generation of antibodies
expressed as 48 hr passive cutaneous anaphylaxis titer.
Materials and methods
Sensitization and antigenic challenge
     Male Wistar, Brown-Norway (BN) and Long-Evans Cinnamon (IEC) rats were
sensitized and received repeated antigenic challenge by the method deseribed in Experiment
2-1.
Passive cutaneous anaphylaxis (PCA)
     To measure 48 hr PCA titer, the blood specimens were obtained from the heart after the
in vivo study under anesthesia as deseribed above. 'Ihe blood specimens were ice-cooled for
10 min and then centrifuged (3000 rpm, 4 Åé for 10 min). The sera obtained were stored at -35
Oc unti1 used•
     Serial dilutions (4-1024) of the serum obtained from individual bleedings were injected
intrademially in O. 05 ml quantities into the shaved backs of normal rats of each strain. After 48
hr, the rats were i.v. injected DNP-Asc (2 mg protein!200 g body weight) together with 1 9o
E.B. (O.5 mvaOO g body weight) into the tail veins. They were exsanguinated from the
abdominal aorta 30 min later, and the skin was refiected for measurement of the extent of
extravasation of the dye. wnen the diameter was 25 mm, the dilution was determined as the
end point.
Drugs
     Evans blue was purchased from Merck (New Jersey, USA).
Stat]tstical analyses
    The PCA titer of each group is expressed as the mean and its statistical significance was
determined by Wilcoxon rank-sum test.
Results
    The antibody titer was measured by 48 hr passive cutaneous anaphylaxis (PCA), 24 hr
after the 1ast antigenic challenge or last saline inhalation in sensitized control group. In the
respective strain of rats, no significant differenoe was observed between the sensitized control
groups and repeated challenged groups (Table 2-1). On the other hand, the mean PCA titer of
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Wistar rats that were subject to repeated antigenic challenge was much and significantly lower
than that of BN rats (pÅqO.Ol), but significantly higher than that of LEC rats (pÅqO.05).
Table 2-1 Strain differences in 48 hr passive cutaneous anaphylaxis (PCA) titers
in DNP-Ascaris sensitized or challenged rats.
Wistar BN LEC
3Sal 3Asc 3Sal 3Asc 3Sal 3Asc
n 5 6
MeanPCAtiter 11.2 30.0ns
PCAtiterrange 4-16 4-64
7
878**
   6
1024ns**
6
6.7
512-1024 1024 4-16
  7
6.3ns*
4-16
BN; Brown-Norway rats, IEC; Long-Evans Cinnamon rats, 3Asc; 3 times
repeated challenge group, and 3Sal; 3 times repeated saline-received group (only
sensitization). Antisera were obtained 24 hr after the 1ast challenge (3Asc) or last
saline inhalation (3Sal) ns; no significant differenoe vs. respective 3Sal group.
'pÅqO.05 and '"pÅqO.Ol vs. respective Wistar group (Wilcoxon rank-sum test).
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Dlscusslon
     As described in CHAPTER 1, repeated antigenic challenge caused a distinct airway
hyperresponsiveness (AHR) and airway inflammation both at in vivo and in vitro levels by
using Wistar strain of rats. The AHR and airway inflammation caused appeared severest 24 hr
after the 1ast antigenic challenge of the 3 times repeated challenge conducted every 48 hr. In the
present study, the strain difference of the pathogenesis of AHR was examined in the strains of
rats exhibiting immunological deviation as well as Wistar strain.
     Brown-Norway (BN) rats have been known as a high IgE responder (Pauwels et al.,
1978; Pauwels et al., 1979). From the veiwpoint of some immunological similarity to humans,
some investigators have used this strain as models ofearly (Bellofiore et at., 1987; Du et al.,
1992) and late asthmatic responses (Eidelman et al., 1988; Xu et al., 1990), antigen-induced
AHR (Bellofiore and Martin, 1988; Elwood et al., 1991) and allergic rhinitis (Takahashi et al.,
1990). Elwood et al. (1991) reported that 7 times repeated challenge with ovalbumin (OA) of
OA-sensitircd BN rats caused AHR to ACh and significant increase in eosinophils and
lymphocytes in bronchoalveolar lavage fiuid (BALF). Based on their report and high
immunoreactivity of the strain, we expected that more marked AHR could be observed in BN
rats than in Wistar rats. However, it turned out that our expectation was disappointed. In the
present study, the AHR to ACh induced by 3 times repeated antigenic challenge was greater in
Wistar rats than in BN rats. On the other hand, it was found that the in vivo airway
responsiveness to ACh in normal BN rats was significantly larger than that in normal Wistar
rats. These findings indicate that BN rats might be a spontaneously hyperreactive strain and
that there might possibly have a limhation for inducing further hyperreactivity because of
ceiling effect. Bellofiore and Martin (1988) revealed that some degree of desensitization to OA
antigen occurred in sensitized BN rats with 6 times repeated antigen inhalation. The
mechanism of desensitization, they said, had yet to be resolved. Possibly, the desensitization
process might be somewhat participated in our results.
     In the present study, the in vitro bronchial responsiveness to ACh and to electrical field
stimulation (EFS) were both significantly augmented 24 hr after the last antigenic challenge in
Wistar rats. On the other hand, in BN rats, no change in the bronchial responsiveness to ACh
was observed, although the responsiveness to EFS was significantly augmented 24 hr after the
last antigenic challenge. We have confirmed in our experiment that the contractile responses
elicited by EFS were completely abolished by tetrodotoxin (10` M) or atropine (10` M),
indicating that the EFS responses were mediated by neural, especially cholinergic component.
'Ihese findings therefore suggest that only a prejunctional hyperfunction (e. g. inereased release
of ACh from the nerve endings) might have occurred in BN rats, whereas smooth muscle
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hypersensitivity to ACh possively with a prejunctional hyperfunction) might have occurred in
Wistar rats after repeated antigenic challenge. BN rats are Iikely to be useful for investigating
some prejunctional changes with the AHR.
     Long-Evans Cinnamon (LEC) strain of rats is a new mutant which develops
spontaneous hepatitis associated with severe jaundice at the age of approximately 4 months
 (Yoshida et al., 1987). It was also reported that this strain of rats has a defect of T cell
maturation, that is, an arrest of differentiation from CD4'8' to CD4'8' thymocytes and
dysfunction of helper T cells (Agui et al., 1990; Yamada et al., 1991). Generally, the helper T
oells are inevitably concerned in the production of immunoglobulin E (IgE) antibodies, so that
the present result representing the lowest PCA titer and minor behavioral change by antigenic
challenge in LEC rats is consistent with this notion. Although the mechanisms of pathogenesis
of AHR have not yet been disclosed, the interrelationship among the late asthmatic response
(IAR), airway inflammation and AHR should be very important (O'Byrne, 1986; Chung,
1986). There is a severe eosinophil infiltration into the airways at LAR (De Monchy et al.,
1985; Hutson et al., 1988). There is also increasing evidence that the infiltrating eosinophlls
cause airway tissue damage and IAR by releasing cytotoxic granules and membrane products
(Frigas and Gleich, 1986; Wegner et at., 1990). In addition to the eosinophil infiltration, the
reoent studies have shown that CD4' T oells increase in the airways at IAR (Metzger et al.,
1987; Frew et al.s 1990), suggesting that CD4' T cells might be involved in antigen-induoed
LAR and AHR. More recently, Nakajima et al. (1992) have demonstrated that the in vivo
depletion of CD4' T oells by pretreatment with anti-L3T4 (CD4) monoclonal antibody
significantly deereased the eosinophil infiltration into the trachea induced by antigen (OA)
inhalation to sensitizod mice. These findings indicate that T lymphocytes, especially CD4' T
cells (generally, a marker of helper T oells), may have an important role in pathogenesis of
antigen-induoed AHR that generally follows LAR. On the other hand, our findings of the
failure in enhancement of the airway responsiveness to ACh (in vivo and in vitro) and electrical
field stimulation (in vitro) in LEC rats after repeated antigenic challenge, may be presumably
due to incomplete sensitization formed, through the defect of T cell maturation.
     In the present study, we determined the bronchial tissue wet to dry (wetldry) weight ratio
as an index of airway edema. As a result, a distinct airway inflammation occurred after
repeated antigenic challenge in Wistar rats. This observation corresponded with our previous
study (Misawa and Chibq 1993) where the Evans blue method and the histological
examination were used. In BN and LEC rats, however, only insignificant increase in the
wetidry weight ratio was observed. We previously demonstrated (Misawa and Chiba, 1993)
that the time courses of both the Evans blue exudation and the AHR to ACh after repeated
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antigenic challenge resembled, indicating a close relationship between the airway inflammation
and AHR. So the strain' differenoe of the pathogenesis of the AHR observed among the three
strains of rats, might be reflected by the strain difference of the extent airway edema; Wistar
strain of rats which showed a significant airway infiammation developed the AHR.
     In our result, the 48 hr PCA titer in BN rats was much higher than that in Wistar rats or
MC rats; the titer in Wistar rats was significantly higher than that in MC rats. Pauwels et al.
(1979) substantiated that there is a genetic influence in the IgE antibody response and that BN
strain of rats was the highest IgE responder among the five inbred strains (BN, Wistar R/A,
DA, LEW and PVGIC rats) they used. Our result on BN strain was consistent with their
findings. Although there had no documentation on the ability of IgE antibody formation in
IEC rats, the present result could be explained by their dysfunction of helper T oe11s as
deseribed above. Interestingly, no correlation was observed between the PCA titer and the
extent of the AHR caused. The reason why the pathogenesis of the AHR disagree with the
extent of the PCA titer in Wistar and BN strains is unknown. BN rats had a high responsivity
to ACh both in vivo and in vitro as desc ribed in the result, so that there might have a limitation
for inducing further hyperreactivity in BN rats. As another possibility, there may be some
functional difference in the mechanism for the AHR induction after the process of IgE
production. Wistar strain of rats may be therefore a suitable strain for the formation of antigen-
induced AHR.
     Presently, we confirrned that the repeated antigenic challenge induoed a distinct AHR,
both in vivo and in vitrD, and airway infiammation in Wistar rats that were sensitized with
DNP-Asc antigen. Some degree of in vtvo but not in vitro ACh hyperresponsiveness was
observed in BN rats, but no significant change in both in vtvo and in vitro ACh
responsiveness was observed in MC rats. It has been reported that an antigenic chadenge to
sensitized guinea pigs (Ishida et al., 1990) and rabbits (Tanaka et al., 1991) resulted in an
airway smooth muscle hyperresponsiveness in vitro. 'Iliese animals also obtained AHR in the
in vivo level (Ishida et al., 1989; Tanaka et al., 1991). 'Ihese findings therefore suggest that
the increased airway smooth muscle responsiveness itself may be refieeted in the in vivo AHR
as a mechanism. In fact, some studies have demonstrated a substantial increase in muscle
responsiveness of isolated airway smooth muscle strips from asthmatics in vitro (Schellenberg
and Foster, 1984; De Jongste et al., 1987; Bai, 1990). In conclusion, Wistar rats may be most
suitable for the model of antigen-induced AHR among the strains used.
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                          CHAPTER 3:
   The mediators involved in the pathogenesis of
antigen-induced airway hyperresponsiveness in rats
Introduction
     'Ihromboxane A, ('IXA,) is a potent constrictor of bronchial smooth muscle that is
formed after activation of platelets, maerophages and other cells (Svensson et al., 1977;
Ullrich & Nusing, 1990).The rolc that TXA, plays in bronchial asthma can be probed by
specific mhibitors of the thromboxane synthase enzyme. For example, inhibitors of
thromboxane synthase have decreased the bronchoconstrictor response to allergen inhalation in
guinea pigs, presumably because of the blockade of [XA, forrnation (Nambu et al. , 1990). As
for AHR, it was recently reported that 'I)ÅqA2 synthase inhibitors prevent AHR induced by
ozone, platelet activating factor (PAF) and antigen in dogs (Aizawa et al. , 1985; Chung et al. ,
1986a; 1986b) and sheep (Abraham et al., 1988). These findings suggest that TXA,,
generated from inflammatory cells and/or airway tissues, may play an important role in the
pathogenesis of AHR. On the other hand, PAF is a potent mediator of inflammation that has
been implicated in the pathogenesis of asthma (Barnes et aL , 1988), and it has been proposed
that PAF is an important mediator in the exacerbation of asthma (Page & Morley, 1986; Barnes
& Chung, 1987). It has also been reported that PAF receptor antagonists inhibit AHR induced
by antigen in guinea pigs (Coyle et al., 1988; Havill et al., 1990).
     In the present study, the effects of a TXA, synthase inhibitor, ozagrel, and a PAF
antagonisg CV-3988, on the antigen-induced AHR were investigated by using our rat AHR
model.
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Experiment 3-1: Effect of a platelet activating factor antagonist on
antigen-induced airway hyperresponsiveness.
Materials and methods
Animals
     Male Wistar rats (6 weeks of age, specific-pathogen-free, 170-190 g) were purchased
from Charles River Japan, Inc. and housed under standard laboratory conditions with free
access to food and water.
Sensitization and antigenic challenge
     The method for inducing AHR was described in Experiment 1-2. Animals were
sensitized with 2,4-dinitrophenylated Ascan's suum extract (DNP-Asc, 2 mg protein, s.c.)
together with Bordetellapemtssis (2xlOiO) as an adjuvant and were boosted by DNP-Agc (O.5
mg protein, i.m.) 5 days later, according to the method of Tada and Okumura (1971). Eight
days after the first immunization, the rats were challenged by inhaling DNP-Asc (6 mg
protein/ml, 5-6 ml) with an ultrasonic nebulizer (TUR-3000, Nihon Kohden, Tokyo) for 20
min under unanesthesia in a plexiglass box (300x200 mm, height: 150 mm): Then the animals
were subjected to 3 times repeated antigenic challenge every 48 hr with the same inhalational
challenge method described above. The sensitized control rats received the same immunization,
but were inhaled saline instead of DNP-Asc.
Limg trearments
     CV-3988 (3 mglkg) was intravenously administered from a tail vein 5 min before each
antigenic challenge. The doses of CV-3988 used in this study was known to selectively
antagonize the PAF-induced response (Misawa & Iwamura, 1990).
Measurement of bronchomotor response
     The determination of airway responsiveness to ACh was done 24 hr after the last
antigenic challenge. Rats were anesthetized with urethane (2 g!kg, i.p.), placed in the supine
position and ventilated artificially through a tracheal cannula at a frequency of 70 breathslmin.
Respiratory volume was adjusted at the beginning of the experiment so that ventilation
overflow (VO) was O.5 ml in each rat. Spontaneous respiration was stopped by pancuronium
bromide (1 mgZkg, i.v.). The bronchomotor tone was measured by the modified Konzett-Rds
sler method (Konzett & R6ssler, 1940) as described in Experiment 1-1. The lung was
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inflated at a fixed volume of air under a constant pressure (5 cmH20), and VO was
continuously recorded with a combination of pneumotachograph (TP-602T, Nihon Kohden)
and integrator (EI-601G, Nihon Kohden). Systemic blood pressure was monitored with a
pressure transducer (DX-300, Nihon Kohden) from a cannula inserted into the left carotid
artery. All the above parameters were recorded on a polygraph (RM-6000, Nihon Kohden).
     ACh solutions (O.OOI-O.03 %) were cumulatively inhaled each for 3 min to rats by
aerosolizing the solution contained in a specially devised plastic cylindrical chamber (capacity:
25 ml) whiCh was introduced in an ultrasonic nebulizer (TUR-3200, Nihon Kohden). The
ultrasonic nebulizer with the plastic chamber was placed into the respiratory circuit for the
aerosolized mist being inhaled into the airways at each time of ventilation.
Drugs
     The following drugs were used: CV-3988 ((RS)-2-methoxy-3-(octadecylcalbamoyloxy)-
propyl-2-(3-thiazolo)ethyl phosphate; Takeda Pharmaceutical Co., Osaka, Japan); 2,4-
dinitrobenzene sulfonic acid sodium salt (Tokyo Kasei Co., Tokyo); aoetylcholine chloride
(Daiichi Phamiaoeutical Co., Tokyo); pancuronium bromide (Sankyo Co., Tokyo); urethane
(Sigma, St. Louis, USA).
     CV-3988 was dissolved in saline. 'Ihe other drugs used in the present study were
dissolved andlor diluted in saline.
Statistical analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student's t-test for unpaired data, Cochran-Cox test or two way aiialysis of
variance (ANOVA). The potency ratio of the in vivo bronchoconstrictor response to ACh was
calculated by parallel line assay.
Results
     Inhalation of four cumulative aerosols of ACh (O.OOI, O.O03, O.Ol and O.03 9o; each
for 3 min) to the anesthetized control rats (that were sensitized and inhaled saline instead of
DNP-Asc, and pretreated with respective vehicle before each saline inhalation; Veh-3Sal
groups) induced a concentration-related inerease in ventilation overdow (V.O.), that is, a
bronchoconstriction (Fig. 3-1). Pretreatment with CV-3988 (3 mgAcg, i.v.) alone had no
significant effect on the airway responsiveness to inhaled ACh (data not shown).
     In the repeatedly antigenic challenged rats that were pretreated with respective vehicle
(Veh-3Asc groups), the conoentration-response curve to inhaied ACh was markedly shifted to
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he left 24 hr after the last antigenic challenge (9.5 times; its 95 9o confidence interval: 4.5-
l6.9, F[,,,,]=56.6, pÅqO.Ol (in Fig. 3-1)) as compared with Veh-3Sal group. Pretreatment with
:V-3988 (3 mgZkg, i.v.) had no significant effect on the inereased airway responsiveness after
' epeated antigenic challenge (Fig. 3-1).
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                       Figure 3-1
The effect of CV-3988 (3 mglkg, i.v.) on airway hyperresponsiveness
 (AHR) to inhaled acetylcholine (ACh) induced by repeated antigenic
challenge in rats. A; Animals that were sensitized and inhaled saline 3
times instead of DNP-Asc antigen, and pretreated with saline (vehicle for
CV-3988, O.1 ml/100 g wt, Lv.) 5 min before each saline inhalation
(n=5). O; Animals that were sensitized and challenged 3 times with
DNP-Asc, and pretreated with saline 5 min before each chailenge (n=5).
e; Animals that were sensitized and challenged 3 times with DNP-Asc,
and pretreated with CV-3988 5 min before each challenge (n=6). Each
point represents the mean with S.E. "pÅqO.05 and "pÅqO.Ol vs. Veh-3Sal
group (unpaired Student's t-test or Cochran-Cox test).
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Experiment 3-2: Effect of a thromboxane A,, synthase inhibitor on
antigen-induced airway hyperresponsiveness.
Materials and methods
Sensitization and antigenic challenge
     Animals were sensitized and
described in Experiment 3-1 .
received repeated antigenic challenge by the method
l]trug treatments
     Ozagrel (100 mglkg,p.o. ) was administered 30 min before each antigenic challenge. The
doses of ozagrel used in this study was known to inhibit thromboxane generation (Takehana et
al., 1990).
Measurement of bronchomotor response
     [he determination of airway responsiveness to ACh was
antigenic challenge by the method described in Experiment 3-1
measured 24hr after the last
.
Drugs
     'Ihe following drugs were used: ozagrel hydrochloride ((E)-3-ip-(IH-imidazol-1-
ylmethyl)phenyl]-2-propenoic acid hydrochloride monohydrate; Kissei Pharmaceutical Co.,
Matsumoto, Japan); 2,4-dinitrobenzene suifonic acid sodium salt (Tokyo Kasei Co., Tokyo);
aoetylcholine chloride (Daiichi Pharmaceutical Co., Tokyo); pancuronium bromide (Sankyo
Co., Tokyo); urethane (Sigma, St. Louis, USA).
     Ozagrel was dissolved in water. The other drugs used in the present study were
dissolved and/or diluted in saline.
Stattstical analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student's t-test for unpaired data, Cochran-Cox test or two way analysis of
varianoe (ANOVA). The potency ratio of the in vivo bronchoconstrictor response to ACh was
calculated by parallel line assay.
Results
     Inhalation of four cumulative aerosols
  of ACh (O.OOI,
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O.O03,'O.Ol and O.03 9o; each
for 3 min) to the anesthetized control rats (that were sensitized and inhaled saline instead of
DNP-Asc, and pretreated with respective vehicle before each saline inhalation; Veh-3Sal
groups) induced a conoentration-related increase in ventilation over[flow (V.O.), that is, a
bronchoconstriction (Fig. 3-2). Pretreatment with ozagrel (100 mgZkg, p.o.) alone had no
significant effect on the airway responsiveness to inhaled ACh (data not shown).
     In the repeatedly antigenic challenged rats that were pretreated with vehicle (Veh-3Asc
groups), the concentration-response curve to inhaled ACh was markedly shifted to the left 24
hr after the last antigenic challenge (5.5 times; its 95 9o confidenoe interval: 3.4-11.0,
F[i,4o]=55•2, pÅqO•Ol (in Fig. 3-2)) as compared with Veh-3Sal group. 'Ihe ACh
hyperresponsiveness after repeated antigenic challenge was significantly attenuated by
pretreatment with ozagrel (100 mglkg, p. o. ) before each challenge (F[,,,,]=8.68, pÅqO.Ol). 'Ihe
airway responsiveness ' to inhaled ACh was significantly inhibited at a concentration of O.03 qo
(pÅqO.05) as compared with Veh-3Asc group. However, this inhibition was only partial: the
ACh responsiveness was stil1 significantly higher than Veh-3Sal group at concentrations of
O.Ol and O.03 9(o (pÅqO.05, Fig. 3-2).
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                       Figure 3-2
The effect of ozagrel (100 mgZkg, p. o. ) on akway hyperresponsiveness
(AHR) to inhaled aoetylcholine (ACh) induced by repeated antigenic
challenge in rats. A; Animals that were sensitized and inhaled saline 3
times instead of DNP-Asc antigen, and pretreated with water (vehicle for
ozagrel, O.2 mVIOO g wt, p.o.) 30 min before each saline inhalation
(n=5). O; Animals that were sensitized and chailenged 3 times with
DNP-Asc, and pretreated with water 30 min before each challenge (n=5).
e; Animals that were sensitized and challenged 3 times with DNP-Asc,
and pretreated with ozagrel 30 min before each challenge (n=6). Each
point represents the mean with S.E. *pÅqO.05 and **pÅqO.Ol vs. Veh-3Sal
group and tpÅqO.05 vs. Veh-3Asc group (unpaired Student's t-test or
Cochran-Cox test).
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Discussion
     In the present study, the airway hyperresponsiveness (AHR) to inhaled acetylcholine
(ACh) induced by repeated antigenic challenge was significantly attenuated by the pretreatment
with a thromboxane A, (TXA,) synthase inhibitor, ozagrel (100 mglkg, p. o.), 30 min before
each antigenic challenge. This finding suggests an important role of TXA, in the pathogenesis
of antigen-induoed AHR in rats. On the other hand, a platelet activating factor (PAF) reoeptor
antagonist, CV-3988, had no effect in our rat AHR.
     It has been well known that TXA, is generated and released by various stimuli from
inflarnmatory ce11s (e.g. mast cells, eosinophils) and airway tissue. U-46619, a stable
thromboxane mimetic, reportedly induced tracheal contraction (Nagai et aL, 1991) and
potentiated the cholinergic contractile response induced by field stimulation (Chung et al. ,
1985). These findings suggest that the released TXA, modulates the airway tone.
Furthermore, Aizawa et al (1985) reported that the AHR to inhaled ACh induced by ozone
exposure was inhibited by ozagrel, and that inhalation of subthreshold conoentration of U-
46619, which did not cause any bronchoconstriction, inereased airway responsiveness to
inhaled ACh in dogs. Similarly, it was also reported that ozagrel prevented the AHR to inhaled
ACh induced by antigenic challenge in dogs (Chung et al., 1986a) and in guinea pigs
(Komatsu et al. , 1990). These observations and our present result suggest .that 'IXA, might
have a key role on the pathogenesis of the AHR. Komatsu et al (1990) reported that the
antigen-induced AHR was completely abolished by pretreatment wnh 100 mglkg of ozagrel
(the same dosage in the present study), although only panial inhibitory effect was observed in
our study. 'Ihe species differences (guinea pigs vs. rats) and/or the differences of drug
administration routes (intraduodenally vs. oral administration) might be involved in the
controversy, but it is probable that other mechanism(s) might be contribute to the pathogenesis
of the AHR in our iat model.
     Although the source of TXA, was not determined in the present study, the mast cells and
polymorphonuclear leukocytes might be involved in, as the following reasons; first, we
previously demonstrated that this rat AHR was inhibited by treatment with anti-allergic drugs
(Misawa et al. , 1991) and it was reported that the IgE-dependent allergic bronchoconstriction
was inhibited by ozagrel in rats (Watanabe & Hayashi, 1990). Secondly, we also
demonstrated the inflammatory cells (e.g. eosinophils) infiltration to airway tissues at antigen-
induced AHR in rats (CHAPTER 1). Funhermore, it was reported that the allergen-induced
late phase bronchoconstriction, probably caused by inflammatory cells and resulted in the
AHR, was inhibited by ozagrel in rats (Watanabe & Hayashi, 1990).
     PAF is also known to be released from inflammatory oells including eosinophils (Lee et
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al. , 1984) and neutrophils (Clark et al. , 1980) etc. and is suggested to cause antigen-induced
AHR in guinea pigs (Coyle et aL , 1988; Havil1 et al. , 1990). However, Chung et al (1986b)
reported that AHR induced by PAF was inhibited by pretreatment with ozagrel in dogs. On the
other hand, it was reported that the structurally unrelated PAF antagonists, CV-3988 and L
652,731, had no effect on the anaphylactic bronchoconstriction although these antagonists
inhibited the PAF-induced bronchoconstriction in guinea pigs (Danko et al., 1988). These
findings suggest that PAF would not be a final andlor important mediator involved in the
asthmatic reaction andlor the pathogenesis of the AHR, although PAF has a potency to cause
bronchoconstriction (Danko et al , 1988; Misawa & Takata, 1988) and AHR (Chung et al. ,
1986b).
     Our results demonstrated that TXA,, but not PAF, is one of the most important
mediators participating in the pathogenesis of the antigen-induced AHR in rats. However,
other mechanism(s) might be implicated in this AHR because the inhibition by ozagrel was
only partial.
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                      CHAPTER 4:
Participation of sensory neuropeptides in the
    pathogenesis of antigen-induced airway
            hyperresponsiveness in rats
Introduction
     Our previous study showed that repeated antigenic challenge, but not sensitization alone,
did cause both marked AHR and airway inflammation (increased permeability and
inflammatory cells infiltration) in rats (CHAPTER 1). There has been considerable interest in
the possible involvement of sensory neuropeptides, such as substance P (SP) and neurokinin
A (NKA), in the airway inflammation, and more reoent studies suggest the importanoe of
sensory neuropeptides in the pathogenesis of AHR induced by cigarette smoke (Daffonchio et
al. , 1990), toluene diisocyanate (Thompson et al. , 1987) and antigen (Matsuse et al. , 1991) in
guinea pigs. However, in these studies, the exact mechanism by which sensory neuropeptides
induce AHR has yet to be resolved. These peptides are localized at unmyelinated C-fiber
afferents and have been considered to play an important role in the direct' (Sekizawa et al.,
1987) andlor indirect (Hall et aL, 1989; Tanaka & Grunstein, 1986) regulation of
tracheobronchial smooth muscle tone. Capsaicin, the pungent agent of hot peppers, is well
known to selectively release and deplete such neuropeptides, and is frequently used as a tool of
physiological andlor pharmacological studies. Therefore, in the present study, at first, the
effect of sensory neuropeptides depletion by systemic capsaicin prooedure on the pathogenesis
of our antigen-induced AHR in rats was investigated.
     It is well known that these neuropeptides are hydrolyzed and inactivated by neutral
endopeptidase (NEP; EC 3.4.24.11; also called enkephalinase), a membrane-bound Zn-
metallopeptidase localized richly at airway epithelial and smooth muscle cells. Recentiy, the
NEP hypoactivity was reported at the AHR induced by o2pne (Murlas et at., 1992) and
acrolein, an aldehyde component of cigarette smoke and smog (Tumer et aL , 1993) in guinea
pigs. These findings suggest that an NEP hypQactive state itself may be involved in the AHR,
including the antigen-induced AHR. We therefore examined the effects of the NEP inhibitor,
phosphoramidon, on the airway responsiveness of our repeated antigenic challenge-induced
airway hyperresponsive rats. Finally, we directly measured the NEP activity of airway tissues
obtained from the repeatedly antigen-challenged rats which showed AHR.
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Experiment 4-1: Effect of sensory neuropeptides depletion on antigen-
induced airway hyperresponsiveness.
Materials and methods
Animals
     Male Wistar rats (6 weeks of age, specific-pathogen-free, 170-190 g) were purchased
from Charles River Japan, Inc. and housed under standard laboratory conditions with free
access to food and water.
Sensitization and antigenic challenge
     The method for inducing AHR was described in Experiment 1-2. Animais were
sensitized wnh 2,4-dinitrophenylated Ascan's suum extract (DNP-Asc, 2 mg protein, s.c.)
together with Bordetellapenassis (2xlOiO) as an adjuvant and were boosted by DNP-Asc (O.5
mg protein, i.m.) 5 days later, aocording to the method of Tada and Okumura (1971). Eight
days after the' first immunization, the rats were challenged by inhaling DNP-Asc (6 mg
proteinlml, 5-6 ml) with an ultrasonic nebulizer (TUR-3000, Nihon Kohden, Tokyo) for 20
min under unanesthesia in a plexiglass box (300x200 mm, height: 150 mm). Then the animals
were subjected to 3 times repeated antigenic challenge every 48 hr with the same inhalational
challenge method described above. The sensitized control rats received the same immunization,
but were inhaled saline instead of DNP-Asc.
In vivo study
     The determination of airway responsiveness to ACh was done 24 hr after the last
antigenic challenge. Rats were anesthetized with urethane (2 g/kg, i.p.), placed in the supine
position and ventilated artificially through a tracheal cannula at a frequency of 70 breaths/min.
Respiratory volume was adjusted at the beginning of the experiment so that ventilation
overflow (VO) was O.5 mi in each rat. Spontaneous respiration was stopped by pancuronium
bromide (1 mgllcg, i.v.). 'Ihe bronchomotor tone was measured by the modified Konzett-R6s
sler method (Konzett & R6ssler, 1940) as described in Experiment 1-1. The lung was
inflated at a fixed volume of air under a constant pressure (5 cmH20), and VO was
continuously recorded with a combination of pneumotachograph (TP-602T, Nihon Kohden)
and integrator (EI-601G, Nihon Kohden). Systemic blood pressure was monitored with a
pressure transducer (DX-300, Nihon Kohden) from a cannula inserted into the left carotid
artery. All the above parameters were recorded on a polygraph (RM-6000, Nihon Kohden).
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    ACh solutions (O.OOI-O.03 9o) were cumulatively inhaled each for 3 min to rats by
aerosolizing the solutiori contained in a specially devised plastic cylindrical chamber (capacity:
25 ml) which was introduced in an ultrasonic nebulizer (TUR-3200, Nihon Kohden). 'Ihe
ultrasonic nebulizer with the plastic chamber was placed into the respiratory circuit for the
aerosolized mist being inhaled into the airways at each time of ventilation.
     In some experiments, the neutral endopeptidase (NEP) inhibitor, phosphorarnidon
(dissolved in saline) was intravenously administered (3 mglkg) 5 min before the determination
of airway responsiveness to ACh. 'Ihis dosage of phosphoramidon had no effects on basal
bronchomotot tone and systemic blood pressure, but in normal nonsensitized rats, the airway
responsiveness to inhaled ACh was markediy inereased after phosphoramidon treatment (see
CHAPTER 5).
     Systemic capsm'cin pretreatment. The capsaicin treatment was done by using the method
of Yonei et al. (1990) with a minor modification. Animals were treated with a total dose of 125
mgllcg capsaicin, given subcutaneously in two inereasing doses over 3 days, 10 days before
starting repeated antigenic challenge. Each dose was given as follows: Day 1, 25 mg!kg; Days
2 and 3, 50 mglkg of capsaicin. Capsaicin was dissolved in 10 9o ethanol-10 9o Tween 80-80
9e saline. To counteract respiratory impairment caused by capsaicin, terbutaline (1 mglkg, s.c.,
60 min before) and aminophylline (25 mglkg, i.p., 30 min before) was pretreated before each
capsaicin treatment under anesthetization with ketamine (50 mglkg, s.c.) and thiopental (40
mglkg, i.p.). The same dosage regimen, including anesthetization, was used in control animals
to deliver an equivalent volume of vehicle (10 9o ethanol and 10 9o Twecn 80 in saline).
Drugs
     The following drugs were used: 2,4-dinitrobenzene sulfonic acid sodium salt (Tokyo
Kasei Co., Tokyo); capsaicin (Wako Pure Chemical Industries, Osaka, Japan); acetylcholine
chloride (Daiichi Pharmaoeutical Co., Tokyo); pancuronium bromide (Sankyo Co., Tokyo);
urethane (Sigma, St. Louis, USA).
     The drugs used in the present studies were dissolved andlor diluted in saline.
Statistical analyses
     All the data are expressed as the mean with S.E. Statistical significanoe of difference was
determined by Student's t-test for unpaired data, Cochran-Cox test or two way analysis of
variance (ANOVA). The potency ratio of the in vivo bronchoconstrictor response to ACh was
calculated by parallel line assay.
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Results
     The airway responsiveness to inhaled ACh was markedly increased 24 hr after the lagt
repeated antigenic challenge (Figs. 4-1). This antigen-induced AHR was significantly
attenuated by systemic capsaicin pretreatrnent; the ACh concentration-response curve of
capsaicin-treated group was significantly shifted to the right (3.2 times; its 95 9o confidenoe
interval: 2.0-4.9, pÅqO.05) as compared with that of vehicle-treated group (Fig. 4-1).
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                     Figure 4-1
The effect of systemic capsaicin pretreatment on the airway
hyperresponsiveness to ACh induced by repeated antigenic challenge in
rats. Animals were sensitized and inhaled saline (Sal; O, A) or DNP-
Asccuris antigen (Asc; e, A) 3 times after pretreatment with capsaicin
(Cap; A, A) or vehicle (Veh; O, e) for3 days. Capsaicin (total dose; 1
mgZkg, s. c. ) was dissolved in 10 % Tween 80 - 10 9o ethanol in saline.
Values are means Å} S.E. from 5 to 14 animals. "pÅqO.05, *'pÅqO.Ol and
'** pÅqO.OOI vs. Veh-3Sal group. tpÅqO.05 and tttpÅqO.OOI vs. Veh-3Agc
group.
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Experiment 4-2: Effect of phosphoramidon on airway responsiveness
after repeated antigenic challenge.
Materials and methods
Sensitization and antigenic challenge
     Animals were sensitized and
described in Experiment 4-1.
received repeated antigenic challenge by the method
In vivo study
     The determination of airway responsiveness to ACh was mcasured 24hr after the last
antigenic chailenge by the method described in Experiment 4-1 .
     The neutral endopeptidase (NEP) inhibitor, phosphoramidon (dissolved in saline) was
intravenously administered (3 mgA(g) 5 min before the determination of airway responsiveness
to ACh. This dosage of phosphoramidon had no effects on basal bronchomotor tone and
systemic blood pressure, but in normal nonsensitized rats, the airway responsiveness to
inhaled ACh was markedly increased after phosphoramidon treatment (unpublished data).
Drugs
     The following drugs were used: 2,4-dinitrobenzene sulfonic acid sodium salt (Tokyo
Kasei Co., Tokyo); acetylcholine chloride (Daiichi Pharmaceutical Co., Tokyo); pancuronium
bromide (Sankyo Co., Tokyo); urethane, phosphoramidon (Sigma, St. Louis, USA).
     The drugs used in the present studies were dissolved andlor diluted in saline.
Stattstical analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student's t-test for unpaired data, Cochran-Cox test or two way analysis of
variance (ANOVA). The potency ratio of the in vivo bronchoconstrictor response to ACh was
calculated by parallel line assay.
Results
     Figure 4-2 shows the in vtvo effect of pretreatment with phesphoramidon on the airway
responsiveness to ACh in the antigen-induced AHR rats• The phosphoramidon-induoed AHR
was no more observed in repeatedly antigefi-challenged rats unlike in normal rats, indicating
that the NEP activity might already have been reduced after repeated antigenic challenge.
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                   Figure 4-2
The effect of phosphoramidon (Phos) on the repeated antigenic challenge-
induced airway hyperresponsiveness to ACh in sensitized rats. Animals
were sensitized and inhaled saline (Sal; A, A) or DNP-Ascarts antigen
(Asc; O, e)3 times, and then pretreated with Sal (A, O) or Phos (3
mglkg, i. v.; A, e) 5 min before measurement of airway responsiveness
to ACh. Values are means Å} S.E. from 5 to 6 animals. 'pÅqO.05,
** pÅqO.Ol and ""'pÅqO.OOI vs. negative control group.
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Experiment 4-3: Effect of repeated antigenic challenge on airway tissue
neutral endopeptidase activity.
Materials and methods
Sensitization and antigenic chaUenge
    Animals were sensitized and reoeived repeated antigenic challenge by the method
described in Experiment 4-1.
Assay ofNEP activity
     Animals were sacrifioed by the blow to the head and exsanguinated, and the trachea and
bronchus were immediately removed and carefully cleaned of adhering connective tissues. 'Ihe
tracheae, main bronchi and superior lobus of left lungs were collected from 7-9 animals to
obtain one preparation for one number of experiment. These tissue segments were
homogenized with Physcotron (NITI-ON, Co. Ltd., Japan: 5 sec X 6; max) in 10 vol of ice-
cold O.32 M sucrose. These whole tissue homogenates were centrifuged (1,500 g, 4 OC for 15
min) and then the resultant supernatants were recentrifuged (50,OOO g, 4 Åé for 15 min). The
resultant pellets were resuspended in 10 vol of ioe-cold 50 mM
tris(hydroxymethyl)aminomethane (Tris) HCI buffer (pH 7.4) and homogenized (5 sec; max).
The suspensions were again oentrifuged (50,OOO g, 4 Åé for 15 min) and the pellets were
resuspended in 10 vol of ice-cold 50 mM Tris HCI buffer (pH 7.4). These membrane
preparations were stored at -80 Åé until use. The protein concentrations of these preparations
were determined by the method of Lowry et al. (1951) in triplicate with bovine serum albumin
as a standard.
     1he airway tissue NEP activity assay was performed by using the membrane
preparations from normal control, sensitized control and repeatedly antigenic challenged rats,
and the results obtained were compared with each other. The NEP activity was determined by
the method of Bateman et all (1989) with a minor modification. The hydrolysis of [D-
Ala2,Met5 ]enkephalin (Tyr-D-Ala-Gly-Phe-Met) by NEP activity was measured following the
appearance of the product Phe-Met. The assay tube (total volume of 100 pa1, containing O.05
mg protein of the membrane preparation) was preincubated with 10'5 M captopri1 and
puromycin withlwithout 10` M phosphoramidon at 37 eC. Ten min later, O.5 mM [D-
Ala2,Met5 ]enkephalin was added in the assay tube and incubated at 37 eC for 10 min. The
reaction was stopped by rapid ice-cooling, and then the suspensions were oentrifuged (50,OOO
g, 4 OC for 15 min). 'Ihe resultant supernatant was directly analyzed tising a high-performanoe
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liquid chromatography (HPLC) system (Jasco, Japan) with a CrestPak C18S column (Jasco,
Japan). It was eluted at 1 ml/min with O.02 qo trifluoroacetic acid/acetonitrile using a one-step
1inear gradient consisting of 10-45 9o acetonitrile for 12 min. Elutions were monitored at 214
nm. Under these conditions, Phe-Met and [D-Ala2, Met5]enkephalin eluted at 5.5Å}O.O and 7.8Å}O.
O min, respectively (Fig. 4-3). Immediately thereafter, acetonitrile was increased to 70 9o
within 2 min and maintained for the ensuing 5 min to wash off the column before subsequent
use. Products detected at 214 nm were identified by coelution with standard. Products were
quantitated by interpolating the peak height to a calibration curve generated with authentic
standard. All the above assays were performed in duplicate.
     We also measured angiotensin converting enzyme (ACE)-like activity of airway tissue
preparations. ACE-like activity vvas calculated by subtracting the generated Phe-Met in the
presence of 10'5 M captopri1 (without phosphoramidon) from that in the absence of 10'5 M
captopri1.
Drugs
     The following drugs were used: 2,4-dinitrobenzene sulfonic acid sodium salt (Tokyo
Kasei Co., Tokyo); Tris (Wako Pure Chemical Industries, Osaka, Japan); phosphoramidon,
captopri1, aminophylline, [D-Ala2,Met5]enkephalin, Phe-Met (Sigma, St. Louis, USA).
     IJhe drugs used for the NEP activity assay was dissolved and diluted in Tris HCI buffer
(pH 7.4).
Stattstical analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student's t-test for unpaired data or Cochran-Cox test.
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                        Figure 4-3
Typical reverse-phasc, high-pressure liquid chromatography profile of
Phe-Met and [D-Ala2,Mct5]enkephalin recovered from the resultant
supcrnatant that was preincubatcd with the normal rat airway prcparation
(see Materials and methods). Thc generated Phe-Met (nmoVmin!mg
protcin) was measured as the NEP activity.
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Results
    Incubation of the airway tissue preparation with [D-Ala2, Met5]enkephalin in the presence
of captopri1 and puromycin caused the generation of Phe-Met (Fig. 4-3). 'Ihe NEP activity,
calculated by the generation of Phe-Met, of normal rat airway tissues was 15.6 Å} O.5
nmoYminlmg protein (n=5) (Fig. 4-4). 'Ihis aodvity was completely blocked by 10` M of
phosphoramidon (O.OÅ}O.1 nmoYminlmg protein, n=3). The sensitization alone had no effect
on the NEP activity (13.8 Å} 1.1 nmoYminlmg protein, n=5). However, the NEP activity was
significantly reduoed 24 hr after the last challenge of 3 times repeated antigenic challenge (9.8
Å} 1.2 nmoYmin/mg protein, n=5); pÅqO.Ol vs. normal group and pÅqO.05 vs. sensitized control
group. Figure 4-5 shows the angiotensin-converting enzyme (ACE)-1ike activity, calculated by
subtracting the generated Phe-Met in the presence or absence of 10-5 M captopri1 (without
phosphoramidon). No significant difference was observed about the ACE-like activity among
the three groups.
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                        Figure 4-4
Neutral endopeptidase (NEP) activity of airway tissue preparation of
normal [Nor; open column], sensitized control [3Sal: sensitized and
inhaled saline 3 times instead of DNP-Ascan's antigen (Asc); vem'cally
striped column] and repeated antigen-challenged (3Asc: sensitized and
challenged 3 times; horizontally striped column) rats. Animals were
sacrifioed at 24 hr after the 1ast antigenic challenge or the last inhalation of
saline, and airway tissues (tracheae, main bronchi and superior lobus of
left lungs) were collected from 7-9 animals to obtain one preparation for
one experiment. These airway tissues were homogenized, and then NEP
activity was measured as described in Materials and methods. Values
are means Å} S.E. from 5 experiments. n.s. ; no significant difference.
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                        Figure 4-5
Angiotensin converting enzyme (ACE)-like activity of airway tissue
preparation of normal [Nor; open column], sensitized control [3Sal:
sensitized and inhaled saline 3 times instead of DNP-Ascan's antigen
(Asc); vertically stn'ped column] and repeated antigen-challenged (3Asc:
sensitized and challenged 3 times; horizontally striped column) rats. ACE-
like activity was calculated as described in Materials and methods. No
significant difference was observed about the ACE-1ike activity among
groups.
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Discussion
     In the present study, the airway hyperresponsiveness (AHR) to inhaled acetylcholine
(ACh) induced by repeated antigenic challenge was significantly attenuated by the depletion of
sensory neuropeptides by using the systemic capsaicin procedure. This finding suggests an
important role of sensory neuropeptides in the pathogenesis of antigen-induced AHR in rats.
On the other hand, intravenous administration of a neutral endopeptidase (NEP) inhibitor,
phosphoramidon (3 mg!kg) alone, increased airway responsiveness to ACh; the dose of
phosphoramidon exerts anti-NEP effect in rats (Umeno at al., 1989; Umeno et al., 1990). This
phenomenon suggests a hypothesis that an NEP hypoactive state itself causes an increased
airway responsiveness in rats. In support of our hypothesis, the NEP activity was indeed
significantly reduced to the extent of about 60 qo at the AHR observed after repeated antigenic
challenge in sensitized rats as compared with that of normal rats (Fig. 4-4). This is the first
study, in our knowledge, that demonstrated the NEP hypoactivity at antigen induced-AHR.
     In the present study, the phosphoramidon-induoed AHR to inhaled ACh was not
observed in the repeatedly antigen-challenged airway hyperresponsive rats (Fig. 4-2), also
suggesting a NEP hypoactive state at the antigen induced-AHR. It is well known that NEP is
localized rich particularly in the epithelium of the airways (Borson, 1991). Therefore, it could
be likely that epithelial cells were denuded after the repeated antigenic chaiIenge. However, the
idea would be denied, because we have previously confirmed histologically that epithelial cells
were not denuded, but moderately changed after the repeated antigenic challenge (e.g.,
increased and hypertrophied goblet cells) (see CHAPTER 1). Although the mechanism of
pathogenesis of the NEP hypoactivity induced by the repeated antigenic challenge was not
examined in the present study, as a possible explanatjon, reactive oxygen species might be
involved in this event. It is reported that hypochlorite (HOCI) appears to have a direct effect on
the NEP of airway epithelial oe11s (Lang & Murlas, 1991; Murlas et al. , 1990) and enhanoes
the airway responsiveness to SP (Murlas et al., 1990). These findings might support our
speculation. It must, however, be taken into consideration that phosphoramidon may affect
endothelin converting enzyme (Okada et aL, 1990) and NEP modulates the effect of other
peptides such as atrial natriuretic peptide (Connell & Jardine, 1990) and endothelin (McKay et
al., 1992).
     It has been known that sensory neuropeptides, such as NKA and SP, are degraded by
not only NEP but also ACE (Shore et al. , 1988; Skidgel et tzL , 1984). We therefore tried to
determine the ACE activity. As shown in Fig. 4-5, no significant change was observed about
the ACE-like activity after repeated antigenic challenge. It is possible that the differenoe of the
distribution of these enzymes might be refiexed in the results; it has been reported, by means
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of immunohistochemical staining, that the ACE activity was localized at the luminal surfaoe of
vascular endothelium, whereas NEP activity was localized within airway epitheliai and smooth
muscle cells (Sekizawa et al. , 1987; Johnson et al. , 1985). We also have a lirde diserepancy
that the ability of phosphorarnidon to inerease airway responsiveness was completely
abolished in the repeatedly antigenic challenged rats although the NEP activity was reduced by
about 40 9o in these animals. It is also possible that airway alteration at repeated antigenic
challenge-induced AHR might be restricted in cells of airway tissue. A further possible reason
would be that the NEP activity was reduoed to a much greater extent at the airway epithelia
than at other airway tissues, which might result in a great hyperresponsiveness when the
antigen was exposed by inhalation. Alternatively, there might be a 1imitation for inducing
funher hyperreactivity in repeatedly antigenic challenged rats that acquired severe AHR, in
terms of a oeiling effect.
     In summary, we have demonstrated that the depletion of neuropeptides by systemic
capsaicin treatment in rats significantly attenuates the development of the AHR after repeated
antigenic challenge. Furthermore, we also have demonstrated that an NEP hypoactive state in
the airways occurs at the antigen-induced AHR in rats. 'Ihese findings, including our previous
study, suggest that repeated antigenic challenge to sensitized rats causes the airway NEP
hypoactivity, which in turn results in the sensory neuropeptides accumulation released by
various stimuli to cause the AHR. However, other mechanisms may also be responsible for
the antigen-induced AHR in rats, because the inhibition of this AHR by systemic capsaicin
treatment was partial in our study. Further study is neoessary to elucidate the mechanisms of
the antigen-induced AHR.
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                            CHAPTER 5:
Effect of neutral endopeptidase inhibition on airway
   responsiveness to acetylcholine in nonsensitized
                             normal rats
Introduction
     The mechanism(s) of airway hyperresponsiveness (AHR) has not been determined.
However, there have been reports suggesting a role of neuropeptides in the development of
AHR (Ladenius et al. , 1991; Matsuse et al. , 1991). Neuropeptide-containing nerves have been
demonstrated to innervate the airways of several species including guinea pig, man (Lundberg
et al., 1984) and rabbit (Black et aL, 1992). Avariety of chemical, physica1 or electrical stimuli
can cause sensory C-fibers to release neuropeptides locally into the innervated stmctures, and
these released neuropeptides can cause wide variety of physiological events such as
bronchoconstriction, bronchial vasodilation, mucus hypersecretion and/or reeruitment of
inflammatory cells into the airway wall (Barnes, 1991; Solway & Leff, 1991). Several studies
 (Hooper et al., 1985a; 1985b) have shown that the effects of endogenous tachykinins are
1imited by neutral endopeptidase (NEP). NEP is a membrane-bound protease that cleaves a
large variety of peptidic hormons in the immediate vicinity of their specific receptors. NEP-like
activity is specifically found in the epithelium, glands, nerves and smooth muscle ceIIs of
tracheobronchial mucosa (Johnson et tzl. , 1985; Ronco et al. , 1988). However, there has been
poor documentation about NEP activity in rat airway tissues. It has been suggested that
inhibition of this enzyme causes the exaggerated actions of both endogenously released and
exogenously applied neuropeptides (Sekizawa et al., 1987a; Sekizawa et al., 1987b;
Thompson & Sheppard, 1988).
     For the purpose of disclosing the mechanism of AHR, we recently developed an animal
model of AHR by using Wistar rats that were actively sensitized with dinitrophenylated-
Asccvrts suum antigen (DNP-Asc) and challenged 3 times by inhaling the aerosolized antigen
 (CHAPTERS 1 and 2). In our recent investigation, this antigen-induced AHR was
markedly attenuated by the depletion of sensory neuropeptides, by using the systemic
capsaicin prooedure before sensitization, indicating that endogenous neuropeptides has an
important role in inducing the antigen-induced AHR in rats (CHAPTER 4). So in the present
study, at first, the effects of inhaled NKA and SP in the presence or absence of NEP inhibitors
on airway responsiveness to acetylcholine (ACh) were investigated 'by using nonsensitized
-
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normal rats. Interestingly, in our results, the pretreatment with NEP inhibitors alone induced
AHR to inhaled ACh. So next, the mechanism(s) of the NEP inhibitors-induced AHR to ACh
were investigated.
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Experiment 5-1: Effects of exogenous neuropeptides and neutral
endopeptidase inhibitors on in vivo airway
responsiveness to inhaled acetylcholine.
Materials and methods
Animals
     Male Wistar rats (8 weeks of age, specific-pathogen-free, 230-310 g) were purchased
from Charles River Japan, Inc. and housed under standard laboratory conditions with free
access to food and water.
In vivo study
     Rats were anesthetized with urethane (2 glkg, i.p.), placed in the supine position and
ventilated artificially through a tracheal cannula at a frequency of 70 breaths/min. Respiratory
volume was adjusted at the beginning of the experiment so that ventilation overflow (VO) was
O.5 ml in each rat. Spontaneous respiration was stopped by pancuronium bromide (1 mglkg,
i.v.). The bronchomotor tone was measured by the modified Konzett-R6ssler method (Konzett
& R6ssler, 1940) as described in Experiment 1-1. The lung was inflated at a fixed volume
of air under a cQnstant pressure (5 cmH,O), and VO was continuously recorded with a
combination of pneumotachograph (TP-602T, Nihon Kohden) and integrator (EI-601G,
Nihon Kohden). Increase in V.O. means bronchoconstriction in this method. Systemic blood
pressure was monitored with a pressure transducer (DX-300, Nihon Kohden) from a cannula
inserted into the left carotid artery. All the above parameters were recorded on a polygraph
(RM-6000, Nihon Kohden).
     ACh solutions (O.OOI-O.03 9o) were cumulatively inhaled each for 3 min to rats by
aerosolizing the solution contained in a specially devised plastic cylindrical chamber (capacity:
25 ml) which was introduced in an ultrasonic nebulizer (TUR-3200, Nihon Kohden). The
ultrasonic nebulizer with the plastic chamber was placed into the respiratory circuit for the
aerosolized mist being inhaled into the airways at each time of ventilation.
    'IIhe effect of inhaled neurokinin A (NKA) or substance P (SP) on the airway
responsiveness to ACh was investigated by using normal rats. Aerosolized NKA (O.OOI 9o),
SP (O.Ol 9o) or its vehicle (saline) was inhaled through a tracheal cannula under anesthesia for
3 min. The neutral endopeptidase (NEP) inhibitor, phosphoramidon (dissolved in saline, 5
min before) or thiorphan (dissolved in 10 9o dimethyl sulfoxide in saline, 15 min before), was
intravenously administered (each 1 or 3 mglkg) before the inhalation of NKA or SP. Control
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rats received respective vehicle injection (O. 1 mVIOO g). Immediately after the inhalation of the
subbronchoconstrictive Concentration of these peptides, the airway responsiveness to ACh was
determined as described above. In another series ofexperiments, theNK-reoeptor antagonist,
 [D-pro2,D-Trp"9]-substance P (O.3 or 3.0 nmoYmin; O.1 mYmin of flow), was infused
through the right jugular vein under anesthesia from 2 min before phosphoramidon injection.
Control animais received saline infusion instead of the antagonist.
     Systemic capsdi'cin pretreatnient. The capsaicin treatment was performed as described in
Experiment 4-1. Animals were treated with a total dose of 125 mglkg capsaicin, given
subcutaneously 10 days before the measurement of airway responsiveness. The capsaicin was
given as follows: Day 1, 25 mg!kg; Days 2 and 3, 50 mglkg of capsaicin. Capsaicin was
dissolved in 10 9o ethanol-10 9e Tween 80-80 9e saline. To counteract respiratory impairment
caused by capsaicin, the rats were pretreated terbutaline (1 mg!kg, s.c., 60 min before) and
aminophylline (25 mglkg, i.p., 30 min before) before each capsaicin treatment under
anesthetization with ketamine (50 mgAcg, s.c.) and thiopental (40 mg!kg, i.p.). 'Ihe same
dosage regimen was used in control animals to deliver an equivalent volume of vehicle (10 9o
ethanol and 10 9o Tween 80 in saline).
     Bilateral cervical vagotomy. In some experiments, animals reoeived surgical vagotomy
10 min before experimental procedure. Briefly, rats were anesthetized and ventilated artificially
as deseribed above, and the right and left cervical vagi were carefully exposed. The nerve
trunks were dissected away from surrounding blood vessels and connective tissues, and were
ligated with silk threads about 2-3 mm apart at 15 mm distal to the respective nodose ganglia.
'Ihen the nerve trunks were cut between the ligatures. Control rats were subjected to sharn
operation with the exposure of both vagi alone.
Drugs
     'Ihe following drugs were used: 2,4-dinitrobenzene sulfonic acid sodium salt (Tokyo
Kasei Co., Tokyo); capsaicin (Wako Pure Chemical Industries, Osaka, Japan); acetylcholine
chloride (Daiichi Pharmaceutical Co., Tokyo); pancuronium bromide (Sankyo Co., Tokyo);
urethane, phosphoramidon, thiorphan, aminophylline, atropine sulfate, carbamylcholine
chloride (carbachol) (Sigma, St. Louis, USA); neurokinin A, substance P, [D-Pro2,D-
Trp"9 ]substance P (Peptide Institute, Inc., Osaka, Japan)•
     Capsaicin was dissolved in 10 9o ethanol-10 9o Tween 80 in saline. Thiorphan was
dissolved in 10 9o dimethyl sulfoxide in saline. The other drugs used were dissolved andlor
diluted in saline.
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Statistical analyses
     All the data are expressed as the mean with S.
determined by Student's t-test for unpaired data,
variance (ANOVA).
E. Statistical significance of difference was
Cochran-Cox test or two way aiialysis of
Results
     Inhaiation of NKA (O.OOI 9o) or SP (O.Ol 9o) alone to anesthetized normal rats had no
significant effect, but NKA slightly augmented the airway responsiveness to inhaled ACh
 (Figs. 5-1 and 5-2). However, a marked AHR was caused after pretreatment with NKA or SP
in the presence of NEP inhibitor, phosphoramidon or thiorphan (1 and 3 mg!kg, i.v.), in a
dose-dependent manner. The concentration-response curves to inhaled ACh were significantly
shifted to the left after treatments wnh the high dose (3 mgAcg) of phosphoramidon and
thiorphan followed by inhalation of NKA (Fp,,,]=167.2: pÅqO.Ol and F[,,,,]=135.5: pÅqO.Ol,
respectively) (Figs. 5-1 and 5-2) and SP (F[,,,,]=49.4: pÅqO.Ol and F[,,,,]=75,O: pÅqO.Ol,
respectively) (Figs. 5-3 and 5-4). Pretreatment with either NEP inhibitor (phosphoramidon,
thiorphan) alone also induced a marked and significant inerease in airway responsiveness to
inhaled ACh, in a dose-dependent manner (Figs. 5-5 and 5-6). Figures 5-7 and 5-8 show the
9o inerease in V.O. at respective ACh concentrations, based on the above results. The
combination of either NEP inhibitor and NKA had the most potent effect on ACh responses
especially at O.OOI to O.O03 9o, while the combination of either inhibitor and $P had a weaker
and no significant effect as compared with the combination of inhibitors and saline (vehicle for
SP) (Figs. 5-7 and 5-8).
     The phosphoramidon-induced AHR to inhaled ACh was completely abolished by the
systemic capsaicin pretreatrnent (Fig. 5-9). The concentration-response curve to ACh in
normal rats that were treated with the combination of phosphoramidon and NKA (but not SP;
data not shown) after systemic capsaicin pretreatment carne to the similar level to that of the
phosphoramidon-induced increased ACh responsiveness. The intravenous infusion of the non-
selective NK-receptor antagonist, [D-Pro2,D-Trp7'9]SP, also inhibited the phosphoramidon--
induced tsuR, dose-dependentiy (Fig. 5-10). These results suggest that endogenous
neuropeptides are involved in the AHR induced by NEP inhibitors. Figure 5-11 shows the
effect of bilateral cervical vagotomy on the increased airway responsiveness to inhaled ACh
after phosphoramidon treatment (3 mg!kg, i. v. ) in normal rats. The phosphorarnidon-induced
AHR was partially but significantly attenuated after treatment with vagotomy (F[,,ss]=6•8:
pÅqO.05). In these experiments, the treatment with systemic capsaicin, the high dose of {D-
Pro2,D-Trp"9 ]SP or bilateral cervical vagotomy aione did not significantly affect the ACh
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fesponse as compared with respective control group.
     'Ihe bronchoconstriction induced by inhaled carbachol (CCh; unmetabolized by
acetylcholinesterase) was significantly greater than that of ACh aerosol at the same
concentrations in normal rats (Fig. 5-12). Nevertheless, the bronchoconstriction induced by
CCh aerosol was also significantly augmented after i. v. treatment with phosphorarnidon (Fig.
5-12).
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                         Figure 5-1
The effects of inhaled neurokinin A (NKA) on the airway responsiveness
to ACh in normal rats. Phosphoramidon (Phos; 1 or 3 mg/kg, i. v.) was
dissolved in saline and pretreated 5 min before NKA inhalation under
anesthesia. NKA (O.OOI 9o) was dissolved in saline (Sal) and inhaled
immediately before measurement of airway responsiveness to ACh.
Values are means Å} S.E. from 5 to 7 rats. *pÅqO.05, ""pÅqO.Ol and
**' pÅqO.OOI vs. Veh-Sal group.
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                Figure 5-2
The effects of inhaled neurokinin A (NKA) on the airway responsiveness
to ACh in normal rats. Thiorphan (Thio; 1 or 3 mgAcg, i.v.) was
dissolved in 10 9o dimethyl sulfoxide in saline and pretreated 15 min
before NKA inhalation. NKA (O.OOI 9o) was dissolved in saline (Sal)
and inhaled immediately before measurement of airway responsiveness to
ACh. Values are means Å} S.E. from 5 to 7 rats. 'pÅqO.05, "pÅqO.Ol and
""' pÅqO.OOI vs. Veh-Sal group.
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                        Figure 5-3
Tl)e effects of inhaled substanoe P (SP) on the airway responsiveness to
ACh in normal rats. Phosphoramidon (Phos; 1 or 3 mglkg, i.v.) was
dissolved in saline (Veh in a and c) and pretreated 5 min before SP
inhalation under anesthesia. SP (O.Ol 9o) was dissolved in saline (Sal)
and inhaled imniediately before measurement of airway responsiveness to
ACh. Values are means Å} S.E. from 5 to 7 rats. "pÅqO.05 and '*pÅqO.Ol
vs. Veh-Sal group.
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                    Figure 5-4
The effects of inhaled substance P (SP) on the airway responsiveness to
ACh in normal rats. Thiorphan (Thio; 1 or 3 mglkg, i.v.) was dissolved
in 10 9o dimethyl sulfoxide in saline and pretreated 15 min before SP
mhalation. SP (O.Ol 9o) was dissolved in saline (Sal) and inhaled
irnmediately before measurement of airway responsiveness to ACh.
Values are means Å} S.E. from 5 to 7 rats. "pÅqO.05, '"pÅqO.Ol and
'"" pÅqO.OOI vs. Veh-Sal group.
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                     Figure 5-5
The effects of neutral endopeptidase inhibitor, phosphoramidon (Phos),
on the aiiway responsiveness to ACh in normal rats. Phos (1 and 3
mg!kg, Lv.) was dissolved in saline and pretreated 5 min before saline
(vehicle for NKA and SP) inhalation under anesthesia. Values are means
Å} S.E. from 5 to 7 rats. 'pÅqO.05, "pÅqO.Ol and '"*pÅqO.OOI vs.
respective Veh group.
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                   Figure 5-6
The effects of neutral endopeptidase inhibitor, thiorphan ('Ihio), on the
airway responsiveness to ACh in normal rats. Thio (1 and 3 mgAcg, i.v.)
was dissolved in 10 9o dimethyl sulfoxide (DMSO) in saline and
pretreated 15 min before saline (vehicle for NKA and SP) inhalation
under anesthesia. Values are means Å} S.E. from 5 to 7 rats. *pÅqO.05,
'" pÅqO.Ol and '*'pÅqO.OOI vs. respective Veh group.
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                        Figure 5-7
Percent changes in ventilation overflow (V. O.) at respective concentration
of ACh (O.OOI-O.03 9o) calculated as peroentages of respective means of
control response (shown in FIGs. 2 and 3). Aerosolized NKA (O.OOI
9o; solid column), SP (O.Ol 9o; snt'ped column) and saline (Sal: vehicle
for NKA and SP; open column) were mhaled for 3 min immediately
before measurement of ACh responsiveness. Phosphoramidon (Phos: 3
mgx{kg, i.v.; left paneD was pretreated 5 min before these peptides
inhaiation. Values are means Å} S.E. from 5 to 7 animals. "'pÅqO.Ol and
""
pÅqO.OOI vs. Phos(3)-Sal group. ttpÅqO.Ol vs. Phos(3)-SP group.
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                        Figure 5-8
Percent changes in ventilation overflow (V. O.) at respective concentration
of ACh (O.OOI-O.03 qo) calculated as percentages of respective means of
oontrol response (shown in FIGs. 2 and 3). Aerosoiized NKA (O.OOI
9o; solid coinmn), SP (O.Ol 9o; striped column) and saline (Sal: vehicle
for NKA and SP; open column) were inhaled for 3 min immediately
before measurement of ACh responsiveness. Thiorphan (Thio: 3 mglkg,
t'v.) was pretreated 15 min before these peptides inhalation. Values are
means Å} S.E. from 5 to 7 animals. ""pÅqO.OOI vs. Phos(3)-Sal group.
tpÅqO.05 and ttpÅqO.Ol vs. Phos(3)-SP group.
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                        Figure 5-9
The effect of systemic capsaicin pretreatment on the phosphoramidon
(Phos)-induoed airway hyperresponsiveness to ACh. Some animals were
pretreated with capsaicin (Cap) for 3 days (day 1; 25 mg/kg, days 2 and
3; 50 mglkg, s.c.), and 10 days later the examination was made. The
other animals were pretreated with vehicle (Veh; 10 9o Tween 80 - 10 9o
ethanol in saline) instead of Cap. At the experimental day (day 11),
animals were pretreated with Phos (3 mg!lcg, iv. ) or saline (Sal) 5 min
before inhalation of Sal (vehicle for NKA) under anesthesia. The airway
responsiveness to ACh was measured immediately after the inhalation of
saline or NKA (O.OOI 9o). Values are means Å} S.E. from 4 to 7 animals.
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                      Figure 5-10
The effect of the nonselective NK-reoeptor antagonist, [D-pro2, D-Trp"9]-
SP, on the Phos-induced airway hyperresponsiveness to ACh. The NK-
receptor antagonist (O.3 and 3 nmoYmin, O.1 mllmin, respectively) was
dissolved in saline and infused from the right jugular vein cannula during
the experiment from 2 min before i.v. Phos administration. Values are
means Å} S.E. from 4 to 8 animals.
- 98-
t..-
.Ng
cs
s
s
Åë
m
"Åë
No
c
.,-,.-
O.75
O.50
O.25
o
--
Q--
--
 - A- -•
.OOI
Sham-Sal
Sham-Phos
Vagotomy-Sal
Vagotomy-Phos
-----.-..-
e
     .O03 .01ACh concentration (o/o)
 Tt-o
 A
.03
                     Figure 5-H
The effect of bilateral cervical vagotomy on the Phos-induced airway
hyperresponsiveness to ACh. Rats were subjected to surgical vagotomy
or sham operation (see METHODS) 10 min before i. v. administration of
Phos (3 mg/kg) under anesthesiq. Values are means Å} S.E. from 4 to 12
animals.
- 99'
t.r.x
,,E.,.
6
s
.s
Åë
m
"Åë
Ne
c
...,
1.00
O.75
O.50
O.25
o
--
o--
CCh
-
 - A- -•
Control
Phosphoramidon
Control
Phosphoramidon
            #
.OOI .O03 .01
  Agonist concen tra tion
T**A
/-6
(o/oJ
.03
                    Figure 5-12
Effects of phosphoramidon (3 mglkg, i. v. ) on the airway responsiveness
to inhaled acetylcholine (ACh) and carbachol (CCh) in normal rats.
Phosphoramidon was pretreated 5 min before measurement of airway
responsiveness to ACh or CCh under anesthesia. Values are means Å}
S.E. from 6 to 14 animals. 'pÅqO.05, **pÅqO.Ol and ""pÅqO.OOI vs. ACh
control group. #pÅqO.05 vs. CCh control group.
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Experiment 5-2: Effects of exogenous neuropeptides and neutral
endopeptidase inhibitors on in vitro airway
responsiveness to inhaled acetylcholine.
Materials and methods
Animals
     Male Wistar rats (8 weeks of age, specific-pathogen-free, 230-310 g) were purchased
from Charles River Japan, Inc. and housed under standard laboratory conditions with free
access to food and water.
In vitro study
     Animals were sacrificed by the blow to the head and exsanguinated, and the trachea and
bronchus were immediately removed and carefully cleaned of adhering connective tissues.
About 5 mm length of the left main bronchus was isolated (8-9 cartilages) and the resultant
tissue ring preparation was then suspended in a 10 ml organ bath at a resting tension of O.5 g.
The isometrical contraction of the circular muscle was measured with a force--displacement
transducer (TB-612T, Nihon Kohden) and recorded on a polygraph (RM-85, Nihon Kohden).
'Ihe organ bath contained modified Krebs-Henseleit solution with the following composition
(mM); NaCl 118.0, KCI 4.7, CaClj 2.5, MgSO, 1.2, NaHCO, 25.0, KH,PO, 1.2 and
glucose 10.0. The buffer solution was maintained at 37 OC and oxygenated with 95 9o O,-5 9o
CO,. During an equilibration period in the organ bath, the tissues were washed three to four
times at 15 to 20 min intervals and equilibrated slowly to a base line tension of O.5 g. Fifteen
min after the last washing, the concentration-response curve to ACh (10'7-10-3 M) was
constructed cumulatively. A higher concentration of ACh was successively added after
attainment of a plateau response to the previous concentration. After determination of
responsiveness to each ACh concentration, the tissues were frequently washed out at 15 to 20
min intervals for following experiments. Under these conditions, reproducible concentration-
response curves were obtained on the same tissue strip. In some experiments, NKA (106 M)
or SP (10` M) was added in the organ bath 10 min before the addition of the lowest
concentration of ACh. The combination of enzyme inhibitors, phosphoramidon (10'6 M),
captopril (10-S M; an inhibitor of angiotensin-converting enryme) and puromycin (10'5 M; an
inhibitor of aminopeptidase), was treated 5 min before the addition of these peptides. Some
tissues received the pretreatment with tetrodotoxin (TTX; 106 M) in the organ bath 5 min prior
to the combination of enzyme inhibitors.
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     The following drugs were used: 2,4-dinitrobenzene sulfonic acid sodium sak (Tokyo
Kasei Co., Tokyo); capsaicin, Tris (Wako Pure Chemical Industries, Osaka, Japan);
aoetylcholine chloride (Daiichi Pharmaoeutical Co., Tokyo); pancuronium bromide (Sankyo
Co., Tokyo); urethane, phosphoramidon, thiorphan, aminophylline, atropine sulfate,
tetrodotoxin, carbamylcholine chloride (carbachol) (Sigma, St. Louis, USA); neurokinin A,
substance P, [D-Pro2,D-Trp"9]substance P (Peptide institute, Inc., Osaka, Japan); Evans blue
(Merck Co., New Jersey, USA) and [3H]QNB (l-[benzilic-4,4'-3H]-quinuclidinyl benzilate,
New England Nuclear, Stevenage, UK).
     Capsaicin was dissolved in 10 9e ethanol-10 9o Tween 80 in saline. Thiorphan was
dissolved in 10 9o dimethyl sulfoxide in saline. 'Ihe other drugs used in the in vtvo and in vitro
studies were dissolved andlor diluted in saline and modified Krebs-Henseleit solution,
respectively. 'Ihe drugs used for the binding assay was dissolved and diluted in Tris HCI
buffer (pH 7.4.) except for [3H]QNB (in water).
Stattstical analyses
     All the data are expressed as the mean with S.E. Statistical significanoe of difference was
determined by Student's t-test for unpaired data, Cochran-Cox test or two way analysis of
variance (ANOVA).
Results
     In the presence of phosphoramidon (10` M) plus NKA (106 M), the concentration-
response curve to ACh was significantly shifted to the left (F[,,,,,]=21.0: pÅqO.Ol), although
not so potently as compared with the case of in vivo study. On the other hand,
phosphoramidon alone had no effect in this case (data not shown). The combination of
phosphoramidon and SP (106 M) had no effect on the ACh response. The increased bronchial
responsiveness to ACh after treatment with phosphorarnidon plus NKA was significantly
inhibited by pretreatment with tetrodotoxin ('ITX; 106 M F[,,,,,]=10.6: pÅqO.Ol); the ACh
        .concentration-response curve after pretreatment with TIX was significantly shifted lower than
that after pretreatment with three respective vehicles (F[,,,,,]=9.4: pÅqO.Ol), although the
maximal responses to 10-3 M ACh had no significant difference.
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                    Figure 5-13
The effects of NKA (106 M) on the responsiveness to ACh of the isolated
main bronchial tissue of normal rats. NKA (10'6 M) was added in the
organ bath 10 min before administration of the lowest concentration of
ACh, and phosphoramidon (Phos; 10` M) was treated 5 min before the
addition of NKA Captopril and puromycin (10"5 M) were present in the
organ bath in al1 experiments. Values are means t S.E. from 7 to 16
animals. Tetrodotoxin (TIX; 10` M) was pretreated 5 min prior to the
addition of Phos. In in vitro study, Phos alone had no significant effect
on the ACh responsiveness (data not shown). Statistical significance (by
ANOVA) was observed between the groups of Veh+Veh+Veh vs.
TIX+Veh+Veh (F[,,,,,]=9,4: pÅqO.Ol), Veh+Phos+NKA (F[,,,,,j=21.0:
pÅqO.Ol) and TIX+Phos+NKA (F[,,,,,]=10.6: pÅqO.Ol), respectively, but
no significant difference was observed in T'rX+Veh+Veh vs.
ITX+Phos+NKA (F[,,,,,]=O.23: pÅrO.05).
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                     Figure 5-14
The effects of SP (10` M) on the responsiveness to ACh of the isolated
main bronchial tissue of normal rats. SP (106 M) was added in the organ
bath 10 min before administration of the lowest concentration of ACh,
and phosphoramidon (Phos; 10'6 M) was treated 5 min before the addition
of SP. Captopril and puromycin (10-5 M) were present in the organ bath
in all experiments. Values are means Å} S.E. from 7 to 8 animals. ln in
vitro study, Phos alone had no significant effect on the ACh
responsiveness (data not shown).
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Experiment 5-3: Effects of neurokinin A and phosphoramidon on airway
microvascular leakage.
Materials and methods
Animals
     Male Wistar rats (8 weeks of age, specific-pathogen-free, 230-310 g) were purchased
from Charles River Japan, Inc. and housed under standard laboratory conditions with free
access to food and water.
DeterminatiDn of airway microvascular lecrkage
     Airway microvascu1ar leakage was quantified by the method described in Experiment
1-6. Rats were anesthetized and ventilated as deseribed above, and Evans blue dye (E.B.; 30
mg/mi in saline, filtered with paper filter), 30 mglkg, and heparin, 600 UAcg, were
administered i.v. 3 min after phosphoramidon administration (3 mgiCkg, i.v.). Two minutes
after the dye injection, NKA (O.OOI 9o) and then increasing concentrations of ACh (O.OOI-
O.03 9o) were inhaled by the method deseribed above. Control rats reoeived saline injection
and saline inhalation instead of phosphoramidon and NKA, respectively. Twenty minutes after
the E.B. administration, the animals were exsanguinated from the abdominal aorteg and then
the thorax was opened and two blunt-ended 13-gauge needles were inserted into the left and
right ventricles toward the aorta and pulmonary artery, respeetively. The right atrium and
pulmonary veins were incised to allow the outflow of perfusate, and the airways and lungs
were perfused with 40-50 ml of 1 9o paraformaldehyde in citrate-buffered saline (pH 3.5) to
remove intravascular dye and to fix the tissues. After then, the trachea, main bronchus and
lungs were removed and their wet weights were measured.
     E.B. was extracted by incubating the tissues in 1 ml (trachea and main bronchus) or 3 mi
(lungs) of 100 9o formamide at 55 OC for 24 hr, and its concentration was determined by light
absorbance at 620 nm (U-2000 spectrophotometer, Hitachi) and by interpolation on a standard
curve of E.B. conoentrations (3. 125-50 pag/ml). E.B. content from each sample was expressed
as nanogram per milligram wet wejght of tissue.
Drugs
     The following drugs were used: 2,4-dinitrobenzene sulfonic acid sodium salt (Tokyo
Kasei Co., Tokyo); acetylcholine chloride (Daiichi Pharmaceutical Co., Tokyo); pancuronium
bromide (Sankyo Co., Tokyo); urethane, phosphoramidon (Sigma, St. Louis, USA);
-
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neurokinin A(Peptide Institute, Inc., Osaka, Japan) and Evans blue (Merck Co.,
USA).
     rlbe drugs used in this study were dissolved andlor diluted in saline.
New Jersey,
Stattstical analyses
     All the data are expressed as the mean with S.E. Statistical significance of differenoe was
determined by Student's t-test for unpaired data or Cochran-Cox test.
Results
     The mierovascular leakage in the trachea, main bronchus and lungs was not significantly
changed by the treatment with phosphoramidon and NKA (Table 5-1).
Table 5-1. Effect of the combination of phosphoramidon (Phos) and neurokinin A
(NKA) on the Evans blue dye (E.B.) exudation of the trachea, main bronchus and
lungs of anesthetized, normal rats
Treatment E.B. exudation (ng/mg wet weirht)
Trachea Bronehus Lungs
SaZ-Sal
     (n=5) 20.7Å}2.3 18.1Å}2.6 13.7Å}1.7
Phos-NKA
     (n=5) 21.8Å}4.4ns 19.0Å}1.6ns 15.8Å}1.9ns
The E.B. exudations of the trachea, main bronchus and lungs are expressed as
nanogram of extravasated E.B. per milligram of respective tissue wet weight (mean
Å} S.E.). Control group (Sal-Sal) received intravenous administration of saline (Sal)
and saline inhalation instead of the combination of phosphoramidon (3 mglkg) and
NKA (O.OOI 9o), respectively, before inhalation of cumulative conoentrations of
ACh (O.OOI-O.03 9o). ns; no significant difiierence vs. Sal-Sal group.
-
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Experiment 5-4: Effects of neuropeptides on the muscarinic receptor
property in airways.
Materials and methods
Animals
     Male Wistar rats (8 weeks of age, specific-pathogen-free, 230-310 g) were purchased
from Charles River Japan, Inc. and housed under standard laboratory conditions with free
access to food and water.
Binding assay
     Airway tissues and lungs were removed as described in Experiment 4-3. 'Ilie
tracheae, main bronchi and superior lobus of left lungs were collected from 7-9 animals to
obtain one preparation for one number of experiment. These tissue segments were
homogenized with Physcotron (NI'II-ON, Co. Ltd., Japan: 5 sec X 6; level max) in 10 vol of
ice-cold O.32 M suerose. These whole tissue homogenates were oentrifuged (1,500 g, 4 OC for
15 min) and then the resultant supernatants were recentrifuged (50,ooO g, 4 Åé for 15 min).
The resultant pellets were resuspended in 10 vol of ice-cold 50 mh
tris(hydroxymethyl)aminomethane (Tris) HCI buffer (pH 7.4) and homogenized (5 sec; level
max). The suspensions were again oentrifuged (50,OOO g, 4 Åé for 15 min) and the pellets
were resuspended in 10 vol of ice-cold 50 mM Tris HCI buffer (pH 7.4). These membrane
preparations were stored at -80 OC until use. 'Ihe protein concentrations of these preparations
were determined by the method of Lowry et al. (1951) in triplicate with bovine serum albumin
as a standard.
     First, we performed [3H]QNB binding assay by using the membrane preparations from
normal rats to characterize the [3H]QNB binding sites as muscarinic ACh receptors. Briefly,
the assay tubes (total volume of 500 pa1 containing O.1 mg protein of the membrane
preparation) were incubated with different conoentrations of [3H]QNB (specific activity 38.8
CYmmol, final concentration of 15.625-2,OOO pM) at 25 OC for 60 rnin. At the end of
incubatjon, the suspension was rapidly flltrated through polyethylenimine-coated Whatman
GFIC glass fiber filter to separate bound [3H]QNB from free [3H]QNB. 'Ihe filter was washed
3 times with 5 ml of 50 mM Tris HCI buffer (pH 7. 4), and then the radioactjvjty was counted
in 10 ml ofscintillation fluid (Aquasol-2; New England Nuclear, Stevenage, UK) by a liquid
scintillation counter (LSA-1600CA liquid scintillation analyzer, Packard). Specific binding
was calculated by subtracting nonspecific binding in the presence of atropine (10` M) from
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total binding in the absenoe of atropine. These prooedures were performed in duplicate, and
then the Scatchard analysis of [3H]QNB binding was done.
     By using these membrane preparations from normai rats, the effect of phosphoramidon,
NKA or SP on the [3H]QNB binding was determined in triplicate. The assay tube (total
volume of 500 pa1 containing O.1 mg protein of the membrane preparation) was preincubated
with the combination of peptidase inhibitors, 10" M of phosphoramidon and 10`5 M of
captopril and puromycin, at 37 OC. Ten min later, NKA or SP (10'6 M) was added in the assay
tube and preincubated at 37 OC for 10 min. After these preincubation periods, the binding assay
was done by using 1 nM of [3H]QNB, as des(uibed above.
Drugs
     The following drugs were used: 2,4-dinitrobenzene sulfonic acid sodium salt (Tokyo
Kasei Co., Tokyo); Tris (Wako Pure Chemical Industries, Osaka, Japan); phosphoramidon,
atropine sulfate (Sigma, St. Louis, USA); neurokinin A, substance P (Peptide Institute, Inc.,
Osaka, Japan) and (3H]QNB (1-[benzilic-4,4'-3H]-quinuclidinyl benzilate, New England
Nuclear, Stevenage, UK).
     The drugs used for the binding assay was dissolved and diluted in Tris HCI buffer (pH
7.4) except for [3H]QNB (in water).
Stattstical analyses
     All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Student's t-test for unpaired data or Cochran-Cox test.
Results
     'Ilie upper panel of figure 5-15 shows the saturation curve obtained from binding assay
using the crude membrane preparation from normal rat airway tissues. The nonspecific
component determined in the presenoe of 10`6 M atropine was 1inear (r=O.997). Specific
binding of [3H]QNB to rat airway tissue membranes was saturable and of high affinity, wkh a
dissociation constant (Kd). of 194.9Å}44.9 pM and a maximal number of binding sites (Bmax)
of 37.7Å}4.2 imoVmg protein (n=6).
     The lower panel of figure 5-15 shows the effect of NKA or SP withlWithout
phosphoramidon, captopril and puromycin on [3H]QNB binding sites of the above membrane
preparations. These peptides andlor inhibitors had no effect on [3H]QNB binding sites at the
[3H]QNB concentration of 1 nM which covers almost all the specific binding sites of these
preparations (Fig. 5-15, upper panel).
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(Legend for Figure 5-15)
         Upper: The saturation curve for [3H]QNB binding to the airway tissue
        erude membrane preparations from normal rats. 'Ihe membrane
        preparations were incubated in duplicate with increasing concentrations of
         [3H]QNB (15.625-2000 pM) in the absence or presenoe of atropine (10`
        M) for 60 min at 25 eC. Specific binding (open circle) was obtained by the
        differenoe between the total [3H]QNB binding and nonspecific binding
         (closed circle) as defined in the presence of atropine. Values are means Å}
        S.E. from 6 experiments. Inset: Typical Scatchard plots of data from
        above preparations. Ihe Kd and Bmax values are 194.9Å}44.9 pM and
        37.7Å}4.2 fmoYmg protein, respectively, from 6 experiments. Lower: The
        effects of NKA and SP withfwithout phosphoramidon (each 10` M) on
         [3H]QNB binding sites of the membrane preparations of normal rat
        airways. The membrane preparations were preincubated with NKA or SP
        withfwnhout inhibitors (phosphoramidon, 10'5 M of captopril and
        puromycin) for 10 min, and then [3H]QNB binding assay was performed
        in triplicate. Values are means Å} S.E. from 6 experiments.
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Discussion
     In the present study, exogenously administered neuropeptides (especially NKA) in the
presence of NEP inhibitors caused AHR to ACh in normal nonsensitized aiiimals in both in
vivo and in vitro experiments. Interestingly, in our present study, intravenous administration
of NEP inhibitor, phosphoramidon or thiorphan (1 and 3 mglkg) alone, also markedly
inereased aiiway responsiveness to ACh, dose-dependently. This finding strongly suggests a
hypothesis that endogenously released sensory neuropeptides might cause the increased airway
responsiveness. On the other hand, exogenously administered NKA itself, at the conoentration
used, had no contractile and vascular permeable effects even in the presenoe of NEP inhibitors
in normal rats.
     Sekizawa et al. (1987b) reported that pretreatment with NEP inhibitor (Leu-thiorphan) of
the isolated ferret trachea potentiated the SP and electrical field stimulation (EFS)
responsiveness. 'Ihis event might be expljcable by the notjon that the NEP existed on epithelial
and smooth muscle membranes cleaves exogenously applied and endogenously released
neuropeptides such as SP and NKA. So, if the NEP activity is blocked by its inhibitor, the
contractile response to these neuropeptides may be augmented. Similar results were obtained in
in vtvo studies using guinea pigs (L6tvail et al., 1990b; Thompson & Sheppard, 1988).
However, in our study, the airway responsiveness to inhaled ACh (not neuropeptides) was
significantly augmented after treatment with NEP inhibitors alone in rats. This observation was
an unexpected finding for us because Thompson and Sheppard (1988) reported that
pretreatment with phosphoramidon (O.5 mglanimal, iv.) had no effect on the airway
responsiveness to inhaled ACh in guinea pigs. In our results, not only phosphoramidon but
also thiorphan caused ACh hyperresponsiveness in vtvo, indicaimg that inhibition of NEP
actiyity might be involved in this hyperresponsiveness. Furthermre, this AHR induced by
phosphoramidon was also observed in case of using CCh (unaffected by aoetylcholinesterase)
aerosol as a contractile agonist (Fig. 5-12), indicating that inactivation of acetylcholinesterase
might not be involved in this AHR. Although the reason why these results were observed in
our study using rats is difficult to explain, species differences (e.g. distribution of NEP
activity, innervation of neuropeptides-containing nerves) might be implicated in this
disagreement.
    In the present study, the phosphoramidon-inducecl AHR to inhaled ACh was completely
abolished by systemic capsaicin treatment, and dose-dependently inhibited by a tachykinin
receptor antagonist, [D-Pro2,D-Trp"9]SP. In the presence of phosphoramidon, the inhalation
of NKA, but not SP, to the capsaicinized rats also caused AHR to ACh aerosol. Furthermore,
it was reported that a cholinergic agonist had an ability to release neuropeptides such as SP and
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NKA in the guinea pig isolated trachea (Martins et tzL , 1991). 'Ihis suggests that inhaled ACh
even slightly caused the release of sensory neuropeptides, which, especially NKA, were
responsible for the NEP inhibitors-induced AHR. However, NKA itself had no direct and/or
indirect effects on the bronchial contractile response in Wistar rats, because the exogenous
administration of NKA (up to the concentration of 10` M) to the rat isolated bronchial tissues
even in the presence of NEP inhibitors caused no contractile response (data not shown).
     Ldrvall et al. (1990a) have shown that inhalation of SP aerosol to anesthetized guinea
pigs caused an increase in lung resistance accompanied by a significant E.B. extravasation and
edema in the airways; this airway edema contributed to the airway obstruction. It has been also
reported that intravenously administered NKA has an ability of edema formation in guinea pig
airways (Tousignant et al., 1993). There are some findings demonstrating a correlation
between the airway inflammatory events and nonspecific AHR induced by ozone, cigarette
smoke, toluene diisocyanate andlor antigen in many species including human (Chung, 1986).
The inhaled NKA concentration used in the present study, however, had no significant effect
on the E.B. exudation (Table 5-1), indicating that the inereased bronchomotor response to
ACh observed in the present study is not due to airway edema. The pretreatment with
phosphoramidon plus NKA, even at the subthreshold concentrations for inducing
inflammation, induoed the AHR to ACh which was not accompanied by increased E.B.
exudation (an index of airway inflammation) in normal nonsensitized rats. It is therefore
interestingly suggested that the airway inflammation, at least enhanced vascular permeability,
might not be an essential condition for inducing the AHR, at least in normal rats.
     Endogenous substances including somatostatin are known to affect the binding site of
muscarinic ACh receptor in the brain (Miyoshi et aL, 1986). Since we suspected that the
postjunctional ACh binding sites might be affected by NKA, the effect of NKA on [3H]QNB
binding sites was examined. As shown in Fig. 5-15, the tissue membrane preparations obtaind
from the normal rat airways had one high affinity binding site of [3H]QNB, and NKA had no
significant effect on [3H]QNB binding. This result suggests that the AHR to ACh induced by
phosphoramidon plus NKA is not due to the increment of the postjunctional muscarinic ACh
reoeptors. The finding thqt the in vitro ACh hyperresponsiveness induoed by exogenously
applied phosphoramidon plus NKA was completely abolished by TIX (Fig. 5-13) also
supports that postjunctional muscarinic ACh receptors were unaffected by the treatment with
phosphoramidon plus NKA.
     The phosphoramidon-induced AHR to inhaled ACh was significantly, but partially
attenuated by bilatera1 cervical vagotomy (Fig. 5-11). This finding raises the possibility that the
enhanoed vagal reflex might be, at least in a part, involved in this AHR. In addition, in our in
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vitro study, the phosphoramidon plus NKA-induced AHR to ACh was completely abolished
by 'ITX treatment. Funhermore, the contractile response to ACh itself was significantly
attenuated by TTX treatment (Fig. 5-13). These observations imply that the exogenously
applied ACh acts on not only airway smooth muscles directly but also airway nerve endings
and!or ganglions which causes the release of sensory neuropeptides and other contractile
transmitter(s); the released neuropeptides, especially NKA, might augment the release of
contractile transmitter(s) in the presence of NEP inhibitors. Hall et al. (1989) reported that low
concentration of tachykinins, that had little effect on intraluminal pressure, caused an increase
in the contractions elicited by stimulation of the preganglionic vagal nerve fibers and
postganglionic (transmural) stimulation in guinea pig innervated tracheal tube preparations; the
order of potency being NKA ÅrÅr SP. They concluded that tachykinins act on NK, receptors on
postganglionic pulmonary parasympathetic nerve terminals, and that activation of the neuronai
receptors may increase the probability of transmitter release from the nerve terminals. From
these findings, it is possible that activation of NK, receptors on postganglionic
parasympathetic nerve by NKA inereases the release of ACh, which in tum augments the
bronchoconstriction induced by exogenously applied ACh. Although the reason is not
identified why phosphoramidon alone had no effect in in vitro study, the network of NKA-
containing innervation might be much reduced by surgical operations in the isolated main
bronchial preparation; the reduced regions possibly importantly participate in the effects of
NKA, in temis of presynaptic neurons, vagal reflex, autonomic ganglia, etc. On the other
hand, in our in vivo system, the preganglionic vagal nerve also seems to be activated, because
the ACh hyperresponsiveness induced by phosphoramidon was partly attenuated by bilateral
cervical vagotomy (Fig. 5-11). These complex, enhanced probability of transmitter release
might be involved in this AHR in vivo.
     In summary, we demonstrated that 1) treatment with NEP inhibitor plus NKA of normal
nonsensitized rats caused AHR to ACh both in vivo and in vitro without inereased vascular
permeability, 2) i.v. treatmentwith NEP inhibitor alone also induoed AHR to inhaled ACh in
normal nonsensitized rats, and 3) this AHR was completely blocked by capsaicin treatment and
inhibited by NK-receptor antagonist, dose-dependently. These findings suggest an important
role of endogenous neuropeptides in the pathogenesis of AHR. We also demonstrated that 4)
the AHR to ACh induced by i.v. administration of phosphoramidon and that induced by in
vitro treatment with phosphoramidon plus NKA were significantly attenuated by pretreatment
with bilateral cervical vagotomy and 'I'IX, respectively, suggesting that sensory
neuropeptides, especialiy NKA, enhance the vagal refiex and/or probability of transmitter
release. Activation of sensory nerve by various stimuli causes the release of sensory
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neuropeptides and the released neuropeptides, especially NKA, in turn enhance the probability
of transmitter release. Tlie deereased NEP activity and enhanced transmitter release might be,
at least in a part, involved in the pathogenesis of AHR. In our present study using NKA, SP
and a nonselective tachykinin antagonist, although the selective NK,- and NK,-receptor
antagonists (or agonists) were not used, the NK,-receptors might be predominantly involved
in these enhanced transmitter release because NKA had more potent effect than SP both in vivo
and in vitro studies.
-
114-
                           CHAPTER 6:
Alteration of Ca2' mobilization contributing to the
bronchia] smooth muscle constriction after repeated
                       antigenic challenge
Introduction
     Nthough various resuks were reported about the in vitro responsiveness of airway
smooth muscles isolated from asthmatic patients (Vincenc et al. , 1983; Roberts et aL , 1984;
Schellenberg & Foster, 1984; Cenina et aL, 1986; Goldie at al., 1986; De Jongste et al., 1987;
Bai, 1990), it has also been reported that asthmatic patients have hyperresponsiveness both in
vivo and in vimo (Roberts et al. , 1984; Schellenberg & Foster, 1984; De Jongste et aL , 1987;
Bai, 1990). For instanoe, airway smooth muscles obtained from in vivo hyperresponsive
patients have in vitro hyperresponsiveness to methacholine (Roberts et al. , 1984). Likewise,
we have recentiy demonstrated both in vtvo and in vitro AHR to acetylcholine (ACh) in rats
that were actively sensitized and repeatedly challenged with aerosolized antigen (CHAPTERS
1 and 2).
     Elucidation of the Ca2' mobilization mechanisms in airway smooth muscles is important
not only for the understanding of the regulatory mechanisms of smooth muscle contra(xion,
but also for the better understanding of the mode of action of the drugs that modulate smooth
muscle activities. The roles of smooth muscle contractions vary greatiy among various organs
to which the muscle cells belong, and ' diversities' in the regulation of smooth muscle activities
has been often emphasized. Difficu1ty in the study of the Ca2' mobilization in smooth muscle
cells has in this apparent complexity. Ca2' ions required for the activation of smooth muscle
contraction may come from the outside of the cells through ion channels on the plasma
membrane or from the intracellular storage sitets) via Ca2' release mechanisms located on the
organella(s). Hitherto, there has been no report about the study in which Ca2' mobility change
in bronchial smooth muscle cells by AHR was examined.
     To understand the mechanisms of the increased responsiveness to ACh, we therefore
examined the effect of extraoellular Ca2' removal on ACh-induoed constriction of bronchial
rings from airway hyperresponsive rats. We also investigated the Ca2'-induced consniction of
bronchial rings from those rats that were depolarized with ACh or high K' in Ca2'-free
medium. The isolated bronchi from airway hyperresponsive rats were compared with
bronchial rings from non-sensitized normal animals.
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Experiment 6-1: Effect of repeated antigenic challenge on
induced bronchoconstriction in Ca2'-free
 acetylcholine-
medium.
Materials and methods
Sensitization and antigenic challenge
     'Ihe method for inducing AHR was described in Experiment 1-2. Male Wistar rats (6
weeks of age, specific-pathogen-free, 170-190 g) were purchased from Charles River Japan,
Inc. and housed under standard laboratory conditions with free access to food and water.
Animals were sensitized with 2,4-dinitrophenylated Ascan's suum extract (DNP-Asc, 2 mg
protein, s.c.) together with Bordetellapertussis (2xlO'O) as an adjuvant and were boosted by
DNP-Asc (O.5 mg protein, i.m.) 5 days later. Eight days after the first immunization, the rats
were challenged by inhaling DNP-Asc (6 mg protein/ml, 5-6 ml) with an ultrasonic nebulizer
(TUR-3000, Nihon Kohden, Tokyo) for 20 min in conscious state in a plexiglass box
(300Å~200 ium, height: 150 mm). Then the animais were subjected to 3 times repeated
antigenic challenge every 48 h with the sanie inhalational challenge method described in
Experiment 1-2.
In vitro determination of airway response
     Animals were sacrificed by the blow to the head and exsanguinated, and the trachea and
bronchus were immediately rernoved and carefully cleaned of adhering connective tissues.
About 5 mm length of the left main bronchus was isolated (8-9 cartilages) and the resultant
tissue ring preparation was then suspended in a 10 ml organ bath by two stainless-steel wires
(O.3 mm diameter) passed through the lumen at a resting tension of 1.0 g. For all tissues, one
end was fixed to the bottom of the organ bath while the other was connected to a force-
displacement transduoer ('IB-612T, Nihon Kohden) for the measurement of isometric force.
The buffer solution contained modified Krebs-Henseleit solution with the following
composition (mM); NaCl 118.0, KCI 4.7, CaCl, 2.5, MgSO, 1.2, NaHC03 25•O, KH2P04
1.2 and glucose 10.0. The buffer solution was maintained at 37 Åé and oxygenated with 95 qo
O,-5 9o CO,. After an equilibration period, the organ bath was replaced with Ca2'-free 106 M
nicardipine contained solution wnh the following composition (mM); NaCl 122.4, KCI 4.7,
MgSO, 1.2, NaHCO, 25.0, KH,PO, 1.2, glucose 10.0 and EGTA O.Ol. Fifteen min later, 1
mM ACh was added. All these functional studies were performed in the presence of 10-6 M
indomethacin. This concentration of indomethacin had no effect on baseline tension and ACh-
induced constriction of bronchial rings from both group (data not shown).
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Drugs
     The fo11owing drugs were used: 2,4-dinitrobenzene sulfonic acid sodium salt (Tokyo
Kasei Co., Tokyo); acetylcholine chloride (Daiichi Pharmaceutical Co., Tokyo) and
nicardipine, ethylene glyco1-bis(6-aminoethyl ether) N,N,N',N'-tetraacetic acid (EGTA),
dimethyl sulfoxide (DMSO), indomethacin (Sigma, St. bouis, USA). Indomethacin and
nicardipine were dissolved in 10 mM N%CO, and DMSO, respectively, for a concentration of
10'` M and administered in the organ bath in a final concentration of 10'6 M.
Statistical analyses
     All the data are expressed as the mean with S.E. Statistical significance of differenoe was
determined by Dannett' s t-test. Values of PÅqO.05 were taken to indicate a significant difference
between groups of data.
Results
     Our previous study revealed that the sensitization procedurc used in the present study
alone had no significant effect by itself on the ACh responsiveness of rat main bronchial
preparations (Experiment 2-2). So in the present study, the bronchial responsiveness was
compared between repeatedly antigen challenged group and nonsensitized normal control
group. On the other hand, the concentration of nicardipine used completely blocked the high
K' (10-90 mM)-induced bronchoconstriction in Ca2' contained normal Krebs solution,
indicating that voltage-dependent Ca2' channels (VDCs) were completely blocked on this
condition.
     Fig. 6-1 shows the 1 mh ACh-induced constriction of rat bronchial rings in the presence
of 10` M nicardipine under Ca2'-free, O.Ol mM EGTA condition. In this condition, 1 mM
ACh generated only a transient phasic constriction in all preparations used. The generated
tension of bronchial rings from repeatedly antigen challenged rats (O.15Å}O.04 g, n=5) was
significantly greater than that from nonsensitized normal control group (O.02Å}O.OO g, n=8;
PÅqO.05).
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                       Figure 6-1
Effect of extracellular Ca2' removai on the contractile response to
aoetylcholine (1 mM) of bronchial rings from nonsensitized normal
control (Norrnal) and repeatedly antigen challenged (3Asc) rats. Bronchial
rings were preincubated with nicardipine (10-6 M) in Ca2'-free, O.Ol mM
EGTA solution for 15 min. Values are means Å} S.E. from 8 (Normal)
and 5 (3Asc) experiments. "PÅqO.05.
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Experiment 6-2: Effect of repeated antigenic challenge on Ca2'-induced
constriction of main bronchus pretreated with
acetylcholine in Ca2'-free medium.
Materials and methods
Sensiti'zatiDn and antigenic challenge
    Animals were sensitized and reoeived repeated antigenic challenge by the method
described in Experiment 6-1.
In vitro determination ofairway responses
     The bronchial rings were prepared as described in Experiment 6-1 and suspended in
the organ bath. After an equilibration period, the organ bath was replaced with Ca2'-free 10`
M nicardipine contained solution with the following composition (mM); NaCl 122.4, KCI 4.7,
MgSO, 1.2, NaHCO, 25.0, KH,PO, 1.2, glucose 10.0 and EGTA O.Ol. Fifteen min later, 1
mM ACh was added and, after attainment of a plateau (almost baseline level) to the
aoetylcholine response, the concentration-response curve to Ca2' (O.1-5.0 mM) was
constructed cumulatively. A higher concentration of Ca2' was sucoessively added after
attainment of a plateau response to the previous concentration. All these functional studies
were performed in the presence of 10" M indomethacin. This concentration of indomethacin
had no effect on baseline tension and ACh-induced constriction of bronchial rings from both
group (data not shown).
Drugs
     The following drugs were used: aoetylcholine chloride (Daiichi Pharmaceutical Co.,
Tokyo) and nicardjpine, ethylene glycol-bis(P-aminoethyl ether) N,N,N',N'-tetraacetic acid
(EGTA), dimethyl sulfoxide (DMSO), indomethacin (Sigma St. Louis, USA). Indomethacin
and nicardipine were dissolved in 10 mM N%CO, and DMSO, respectively, for a
concentration of 10-` M and administered in the organ bath in a final concentration of 10'6 M.
Stattstical analyses
    All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Dannett' s t-test. Values of PÅqO.05 were taken to indicate a significant difference
between groups of data.
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Results
     Fig. 6-2 shows the concentration-response curves to Ca2' of rat bronchial rings that were
preincubated with 106 M nicardipine and 1 mM ACh under Ca2'-free, O.Ol mM EGTA
condition. The addition of Ca2' induced a concentration-dependent constriction in either group.
[he contractile responses to Ca2' of the acetylcholine stirnulating muscles were markedly
increased after repeated antigenic challenge.
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                        Figure 6-2
Cumulative concentration-response curves to Ca2' of bronchial rings from
nonscnsitized normal control (Normal; O) and repeatedly antigen
chailenged (3Asc; e) rats. Bronchial rings were preincubated with 10` M
nicardipine and 1 mh aoetylcholine in Ca2'-free, O.Ol mM EGTA
solution. Values are means Å} S.E. from 8 (Normal) and 5 (3Asc)
experiments. *PÅqO.05.
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Experiment 6-3: Effect of repeated antigenic challenge on Ca2'-induced
constriction of main bronchus pretreated with high K'
in Ca2'-free medium.
Materials and methods
Sensitization and antigenic challenge
    Animals were sensitized and reoeived repeated antigenic challenge by the method
described in Experiment 6-1.
In vitro determination ofairway responses
     The bronchiai rings were prepared as described in Experiment 6-1 and suspended in
the organ bath. After an equilibration period, the organ bath was replaoed with Ca2'-free 10`
M nicardipine contained solution with the following composition (mM); NaCl 122.4, KCI 4.7,
MgSO, 1.2, NaHCO, 25.0, KH,PO, 1.2, glucose 10.0 and EGTA O.Ol. Fifteen min later,
bronchial smooth muscles were deporalized with 60 mM K' in the presenoe of 10" M atropine
in the Ca2'-free solution. Five min later, the concentration-response curve to Ca2' (O.1-5.0
mM) was constructed cumulatively. A higher concentration of Ca2' was successively added
after attainment of a plateau response to the previous concentration. All these functional studies
were performed in the presence of 106 M indomethacin. This concentration of indomethacin
had no effect on baseline tension and high K'-induced constriction of bronchial rings from
both group (data not shown).
Drugs
     The following drugs were used: atropine sulfate, ethylene glycol-bis(P-aminoethyl ether)
N,N,N',N'ny-tetraacetic acid (EGTA) and indomethacin (Sigma, St. Louis, USA).
Indomethacin was dissolved in 10 mM N%CO, for a concentration of 104 M and administered
in the organ bath in a final concentration of 10'6 M.
Stattstical analyses
    All the data are expressed as the mean with S.E. Statistical significance of difference was
determined by Dannett' s t-test. Values of PÅqO.05 were taken to indicate a significant difference
between groups of data.
-
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Results
    Fig. 6-3 shows the concentration-response curves to Ca2' of rat bronchial rings that were
predepolarized with 60 mM K' under Ca2'-free, O.Ol mM EGTA condition. 'IIhe addition of
Ca2' induced a concentration-dependent consniction in either group. 'Ihe responses to Ca2' of
the bronchial muscles depolarized with 60 mM K' (in the presence of 106 M atropine) were
considered identical between groups.
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Cumulative concentration-response curves to Ca2' of bronchial rings from
nonsensitized normal control (Normal; O) and repeatedly antigen
challenged (3Asc; e) rats. Bronchial rings were deporalized wnh isotonic
60 mM K' in Ca2'-free, O.Ol mM EGTA solution. Values are means Å}
S.E. from 8 (Normal) and 5 (3Asc) experiments.
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Discussion
     Airway smooth muscles are predominantly innervated by vagal efferent nerves, which
release ACh when stimulated and subsequently activate muscarinic cholinergic receptors. The
activation of muscarinic receptors existing on airway smooth muscle, that is mainly thought to
be M, subtypes (Yang et al., 1993), resuks in smooth muscle contraction by inereasing
intraoellular Ca2' conoentration ([Ca2']i): i e. through Ca2' release from sarcoplasmic reticulum
and Ca2' influx from voltage-dependent (VDCs) and receptor-operated Ca2' channels (ROCs)
(Bames, 1990b; Montano et al. , 1993; Rodger & Pyne, 1992). Therefore, the increased ACh
response of isolated bronchus from airway hyperresponsive rat may be attributable to
enhanced Ca2' mobilization at the AHR.
     In the present study, no significant difference between groups in the contractile
responses to cumulatively administered Ca2' was observed in bronchial muscles that were
predepolarized with 60 mM K' (Fig. 6-3), suggesting that no change in VDCs function oocurs
in bronchial smooth muscles of airway hyperresponsive rats. Taking this into consideration, it
is unlikely that enhanced VDCs function is involved in the inereased ACh responsiveness of
the bronchus isolated from repeatedly antigen challenged rats. This might have relevanoe to the
early finding that VDC-blocking drugs such as nifedipine have no effect for asthma therapy
(Ferrari et al. , 1989). On the other hand, the Ca2'-induoed constriction of the muscles, that
were preincubated with 1 mM ACh in the presenoe of 10" M nicardipine in Ca2'-free O.Ol mM
EGTA solution, was much greater in the AHR group than that in the normal group (Fig. 6-2).
Furthermore, on this condition, the contractile response to ACh of bronchial rings from
repeatedly antigen challenged rats was always significantly greater than that from control rats
 (Fig. 6-1). These findings strongly suggest that enhanced Ca2' release from intrace11ular
stores andlor influx from ROCs rather than from VDCs might be involved in the increased
responsiveness to ACh of isolated bronchus from airway hyperresponsive rats.
     It has been thought that activation of M, receptors promotes inositol 1,4,5-trisphosphate
(IP,) generation via activation of the effector enzyme, phospholipase C in airway smooth
muscles. It has also been suggested that IP3 stimulates the release of Ca2' from sarcoplasmic
reticulum, and inositol 1,3,4,5-tetrakisphosphate (IP,; the metabolite of IP, by IP3 kinase) may
be responsible for opening putative ROCs (Luckhoff & Clapham, 1992; Rodger & Pyne,
1992), although the later process has not yet been demonstrated in muscle oe11s. Alternatively,
it has been reported that activation of protein kinase C by diacylglycerol, another metabolite of
phosphatidylinositol by phospholipase C, enhances Ca2' sensitivity for smooth muscle
contraction (Ozaki et al. , 1990: Sato et al. , 1992). Thus, although we do not yet understand
whether increment of [Ca2']i level or enhanoement of Ca2' sensitivity occurs in this
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phenomenon, we speculated that the resultant enhanced phosphatidylinositol turnover system
in airway smooth muscles via the increased Ca2' efficacy might be involved in the AHR in
rats.
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SUMMARY
   Airway hyperresponsiveness (AHR) is a critical component in bronchial asthma, but the
underlying mechanisms remain to be disclosed. Our first study in Chapter 1 was performed to
establish a new good experimental animal model of AHR. Male Wistar rats actively sensitized
with DNP-Ascon`s antigen (DNP-Asc) were challenged by inhaling DNP-Asc 8 days after the
first immunization (single antigenic challenge). Another sensitization group received 3
challenges every 48 hr (repeated antigenic challenge). The airway responsiveness to
inhalations of acetylcholine (ACh) and neurokinin A (NKA) were determined under
anesthesia. The airway microvascular leakage was also determined with Evans blue (E.B.). At
24 hr after the single antigen challenge, the in vtvo airway responsiveness to ACh and NKA
were slightiy enhanced, and the E.B. exudation was increased in the main bronchus. In
contrast, the in vivo airway responsiveness to ACh and NKA and the E.B. exudation in the
main bronchus were much more markedly enhanoed 24 hr after the repeated antigenic
challenge. 'Ihe isolated main bronchial strip from the challenged rats also aequired AHR
towards ACh and serotonin. Tliese findings suggest that repeated antigenic challenge causes a
distinct AHR, both in vivo and in vitro, and that the airway infiarrllnati6n may be closely
related to pathogenesis of AHR.
   In Chapter 2, strain differences in pathogenesis of antigen-induced AHR were investigated
in Brown-Norway (BN) strain of rats, a high IgE responder, Long-Evans Cinnamon (LEC)
strain of rats that has dysfunction of helper T cells, and Wistar strain of rats. Male BN, LEC
and Wistar rats were actively sensitized with DNP-Asc together with Bordetella pertussis
vaccine as an adjuvant. Five days later, the animals were boosted by DNP-Asc. At eight days
after the first immunization, they were challenged by inhalation of the aerosolized DNP-Asc
under unanesthesia. Three times repeated antigenic challenge was performed by inhaling DNP-
Asc every 48 hr to sensitized rats. Twenty four hr after the last antigenic challenge, the in vivo
airway responsiveness to cumulatively inhaled ACh was determined with modified Konzett-R6s
sler method under immobilization and anesthesia. In Wistar rats, the airway respbnsiveness to
inhaled ACh was significantly enhanced after repeated antigenic challenge, but not in BN and
I.EC rats. In in vitro studies, the response to cumulatively administered ACh of the isolated
main bronchus from repeated antigenic challenged group was significantly augmented in
Wistar rats, but not in BN and LEC rats. Only in Wistar rats, the wetidry weight ratio of the
left main bronchus, an index of airway tissue edem& was significantly increased after repeated
challenge. The 48 hr PCA titer in BN rats was much higher than that in Wistar rats. These
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results indicate that severe airway infiammation and AHR were induced in Wistar rats after
repeated antigenic challenge, suggesting the relationship between AHR and airway
inflammation, but not between AHR and serum IgE titer. Wistar rats may be most suitable for
the model of antigen-induced AHR among the strains used.
   ln Chapter 3, the effects of ozagrel, a thromboxane A, (TXA,) synthase inhibitor, and
CV-3988, a platelet activating factor (PAF) antagonist, on the repeated antigenic challenge-
induced AHR in rats were investigated. Rats were actively sensitized with DNP-Ascuris
antigen and received 3 inhalations of antigen (challenges) or saline (sensitized control) every
48 hr. These animals were also pretreated with ozagrel (100 mglkg, p. o. , 30 min before), CV-
3988 (3 mglkg, i. v. , 5 min before) or respective vehicle (water and saline, respectively) before
each inhalation of antigen or saline. The in vivo airway responsiveness to cumulatively inhaled
ACh (O.OOI-O.03 9e, each for 3 min) was measured 24 hr after the last inhalation of antigen or
saline under anesthesia. A marked AHR was observed after repeated antigenic challenge as
compared with sensitized control group (5.5-9.5 times in potency). This AHR was
significantly, but partly, attenuated by pretreatment with ozagrel although this treatment alone
had no effect on the airway responsiveness to inhaled ACh in sensitized control animals. On
the other hand, CV-3988 had no inhibitory effect on this AHR. These findings suggest that
TXA,, but not PAF, is one of the most important mediators partjcipating in the pathogenesjs of
the antigen-induced AHR in rats.
   In Chapter 4, the role of sensory neuropeptides in the AHR was investigated. First, the
effect of the depletion of sensory neuropeptides by systemic capsaicin treatment on the AHR to
ACh induoed by repeated antigenic challenge to sensitized rats was studied. We secondly
investigated whether the neutral endopeptidase (NEP) activity was altered at the antigen-
induced AHR. Male Wistar rats were sensitized and repeatedly challenged with DNP-Ascan's
antigen. Twenty-four hours after the last antigenic challenge, a marked AHR to inhaled ACh
(O.OOI-O.03 9o) was observed. This AHR was significantly attenuated by systemic capsaicin
pretreatment prior to sensitization. On the other hand, in normal rats, the airway
responsiveness to inhaled ACh was significantly increased by pretreatment with NEP
inhibitor, phosphoramidon (3 mg!kg, i.v.), but the NEP inhibitor-induoed effect was no more
observed in the antigen-induced AHR rats. Funhermore, it was found that the airway NEP
activity was significantly deereased at the antigen-induced AHR. These findings suggest that
NEP hypoactivity and resultant inereased sensory neuropeptides have an important role in the
pathogenesis of antigen-induced AHR in rats.
   In Chapter 5, the effects of sensory neuropeptides, NKA and substanoe P (SP), on the
airway responsiveness to ACh were investigated both in vtvo and in vitro by using normal
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nonsensitized rats. The airway responsiveness to inhaled ACh was markedly and significantly
increased after treatment with NKA (O.OOI 9o) or SP (O.Ol %) aerosol in the presenoe of the
NEP inhibitor, phosphoramidon or thiorphan (1 and 3 mgA(g, i.v.). NKA had more potent
effect than SP. interestingly, the tv. treatment with NEP inhibitor alone also induced AHR to
inhaled ACh. This AHR was significantly attenuated by pretreatment with a nonselective NK-
receptor antagonist, ID-pro2,D-Trp7'9]-Sp, systemic capsaicin or bilateral cervical vagotomy,
indicating that decreased NEP activity results in accumulation of endogenous sensory
neuropeptide(s) and enhancement of vagal reflex to cause the AHR. [3H]QNB binding of the
airway tissue membrane preparations of normal rats was not significantiy affected after
preincubation with phosphoramidon and/or NKA On the other hand, the airway
responsiveness to ACh of isolated left main bronchus was also inereased after treatment with
10'6 M NKA, but not SP, together with 10` M phosphoramidon. This in vitro AHR to ACh
                                                                            6induced by phosphoramidon plus NKA was significantly attenuated by pretreatment with 10
M tetrodotoxin. These findings suggest that over-accumulated sensory neuropeptides,
especially NKA, may enhance the probability of transmitter release, probably via the NK,-
receptors, and that these enhanced probability of transmitter release might be involved in the
AHR in rats.
   In Chapter 6, the origin of Ca2' contributing to the enhancement of ACh-induoed bronchial
smooth muscle constriction in AHR evoked by antigen challenge was investigated. Under
ca2'-free (concomitant with lo'6 M nicardipine) condition, the contractile responses of
bronchial rings to 1 mM ACh were significantly greater in airway hyperresponsive rats (O. 15Å}O.
04 g) than those in normal rats (O.02Å}O.OO g; PÅqO.05). The cumulatively administered Ca2'
induced a markedly greater bronchoconstriction in airway hyperresponsive rats in Ca2'-free
solution when muscles were pretreated with 1 mM ACh (in the presenoe of 10` M nicardipine)
than in normal rats, whereas no significant differenoe in Ca2' induced bronchoconstriction was
observed between the two groups when muscles were pretreated with 60 mM K' (in the
presence of 10` M atropine). These findings suggest that enhancement of availability of Ca2'
released from intracellular stores and/or influxed through receptor-operated Ca2' channels in
airway smooth muscles might be implicated in the AHR to ACh in rats.
-
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CONCLUSION
     In my present research, a good animal model of airway hyperresponsiveness (AHR) in
ailergic bronchial asthma was developed in rats. The mechanisms involved in the pathogenesis
of AHR disclosed by using this AHR model are shown below:
1. A close relationship between the bronchial inflammation and developed AHR was
demonstrated after repeated antigenic challenge to sensitized rats. This in vivo AHR is, at
least in a part, ascribable to an inereased bronchial smooth muscle responsiveness itself
as shown in in vitro experiments.
2. Wistar strain of rats is the most suitable for the model of antigen-induced AHR and
airway inflammation out of the strains tested: Wistar, Brown-Norway and Long-Evans
Cinnamon.
3. Thromboxane A2, but not platelet-activating factor, may be one of the most important
mediators involved in the pathogenesis of antigen-induced AHR in rats.
4. The neutral endopeptidase hypoactivity in the airways and resultant increased
endogenous sensory neuropeptides have an important role in the pathogenesis of
antigen-induced AHR in rats.
5. As a role of sensory neuropeptides in the pathogenesis of AHR, activation of the NK2-
receptors on excitatory nerves by endogenous neurokinin A may enhance the transmitter
release in the airways, which results in the enhanced bronchoconstriction (i. e. , AHR) in
rats.
6. The enhancement of availability of Ca2' released from intracellular stores and/or infiuxed
through receptor-operated Ca2' channels, not through voltage-dependent Ca2' channels,
in airway smooth muscles might be involved in the AHR to acetylcholine in rats.
-
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